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ABSTRACT 
 
Infections caused by Clostridium difficile have increased steadily over the 
past several years. While studies on C. difficile virulence and physiology have 
been hindered, in the past, by lack of genetic approaches and suitable animal 
models, newly developed technologies and animal models allow for improved 
experimental detail. One such advance was the generation of a mouse-model of 
C. difficile infection. This system was an important step forward in the analysis of 
the genetic requirements for colonization and infection. Equally important is 
understanding the differences that exist between mice and humans. One of 
these differences is the natural bile acid composition. Bile acid-mediated spore 
germination, a process whereby a dormant spore returns to active, vegetative 
growth, is an important step during C. difficile colonization. Mice produce several 
different bile acids that are not found in humans (muricholic acids) that have the 
potential to impact C. difficile spore germination. In order to understand potential 
effects of these different bile acids on C. difficile physiology, we characterized 
their effects on C. difficile spore germination and growth of vegetative cells.  We 
found that the mouse-derived muricholic acids affect germination similarly to a 
previously-described inhibitor of germination, chenodeoxycholic acid.   
Chenodeoxycholic acid was previously demonstrated to be a competitive 
inhibitor of C. difficile spore germination, though with what the inhibitors or 
activators of germination interacted was unknown.  However, the inhibitory 
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property of chenodeoxycholic acid was used in a screen to identify potential 
germinant receptors and led to the identification of the germination-specific, 
pseudoprotease, CspC, as the bile acid germinant receptor.  
Based on the hypothesized location of CspC within the C. difficile spore 
(cortex rather than inner membrane), we hypothesized that there may be 
differences between the order of the stages of C. difficile and Bacillus subtilis 
spore germination. Germination in B. subtilis, a well-studied spore-former, is 
divided into two genetically separable stages. Stage I is characterized by the 
release of dipicolinic acid (DPA) from the spore core. Stage II is characterized by 
cortex degradation, and stage II can be activated by the DPA released during 
stage I. Thus, DPA release precedes cortex degradation during B. subtilis spore 
germination. To understand how the different location of the C. difficile 
germinant receptor affects the order of DPA release and cortex degradation, we 
first investigated the timing of DPA release and cortex degradation during C. 
difficile spore germination and found that cortex degradation precedes DPA 
release. Based on this result and work with SpoVAC in B. subtilis, we then 
investigated germination under high osmolyte concentrations.  Because both 
cortex degradation and DPA release during C. difficile spore germination are 
dependent on the presence of the germinant receptor and cortex degradation, 
the release of DPA from the core may rely on the swelling of the core upon 
cortex degradation.  
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NOMENCLATURE 
 
AGFK L-asparagine, glucose, fructose and K+ ions 
AMA α-muricholic acid 
BHIS brain heart infusion supplemented with 5 g / L yeast extract 
and 0.1% L-cysteine 
BMA β-muricholic acid 
CA cholic acid 
CaDPA 1:1 chelate of DPA with calcium 
CDCA chenodeoxycholic acid 
CDI Clostridium difficile Infection 
CROP combined repetitive oligopeptide repeat 
DCA deoxycholic acid 
DNA deoxyribonucleic acid 
DPA dipicolinic  acid 
FC 5-fluorocytosine 
FZD Wnt receptor frizzled family 
GCW germ cell wall 
GTD glucosyltransferase domain 
Ki apparent inhibitory constant 
Km apparent rate of germination 
LB medium Luria-Bertani medium 
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LCA lithocholic acid 
NAG N-acetylglycosamine 
NAM N-acetylmuramic acid 
OD600 optical density at 600nm 
OMA ω-muricholic acid 
PG peptidoglycan 
PGA 3-phosphoglyceric acid 
PYG media peptone yeast glucose medium 
RNA ribonucleic acid 
SASPs small acid soluble proteins 
SCLEs spore cortex lytic enzymes 
sirA sporulation inhibitor of replication A 
SNPs single-nucleotide polymorphism 
TA taurocholic acid 
TBS Tris-buffered saline 
TBST TBS supplemented with 1% (vol / vol) Tween*20 
TcdA Clostridium difficile Toxin A 
TcdB Clostridium difficile Toxin B 
UDP-glucose uridine diphosphate glucose 
UV Ultraviolet light 
WT wild-type 
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CHAPTER I 
INTRODUCTION TO SPORE FORMATION IN BACILLUS SUBTILIS AND 
CLOSTRIDIOIDES DIFFICILE AND GERMINATION IN BACILLUS SUBTILIS, 
CLOSTRIDIUM PERFRINGENS AND CLOSTRIDIOIDES DIFFICILE 
Introduction 
Clostridioides difficile (formerly Clostridium difficile) is a pathogenic 
bacterium from Phylum Firmicutes in the Family Peptostreptococcaceae, based 
on 16S rRNA sequencing [1]. Clostridioides are Gram-positive, strictly anaerobic 
bacilli that commonly are motile and produce spores [1]. In PYG media, cells 
produce straight- and branched-chain saturated and unsaturated fatty acids. 
During growth, C. difficile cells produce chains of two to six cells in an end-to-
end alignment. During nutrient limitation, C. difficile vegetative cells undergo a 
developmental program that results in the formation of dormant endospores. 
Spores are ovular in shape and swell the cell when they form, resulting in the 
characteristic ‘club form’ of the cell [1-3].   
Originally identified in 1935, C. difficile was found in the colonic microflora 
of healthy, newborn infants [4]. The difficulty presented in culturing the bacterium 
led to the organism originally being named Bacillus difficile. In 1978, Onderdonk 
and colleagues demonstrated that C. difficile causes disease 
(pseudomembranous colitis) in antibiotic-treated hamsters and that it could be 
isolated from the diseased animals, thus fulfilling Koch’s postulates [5]. 
Importantly, this work demonstrated that the application of antibiotics, 
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specifically clindamycin, was necessary to render the host susceptible to 
infection [5]. Due to the anaerobic nature of the colonic environment, C. difficile 
can colonize and cause disease after the bacterial diversity has been altered 
through the application of broad-spectrum antibiotics [6].  The normal colonic 
microbiome is known to provide ‘colonization resistance’ against invading 
pathogens, though the mechanisms of this protection are unknown [6]. 
C. difficile infection (CDI) most-commonly presents as cramping and 
diarrhea. Severe cases of CDI may result in pseudomembranous colitis, toxic 
megacolon and/or death [5, 7]. The symptoms of CDI are associated with the 
production and secretion of two toxins, TcdA (toxin A) and TcdB (toxin B) [7-13]. 
It is hypothesized that toxin B is responsible for clinical symptoms of disease in 
humans because strains encoding only toxin A are rarely identified in human 
clinical samples [14, 15]. The toxins are cytotoxic and composed of four different 
structural domains: the glucosyltransferase domain (GTD), the cysteine protease 
domain, the translocation domain and the receptor binding domain [a combined 
repetitive oligopeptide repeat (CROP) domain] [16]. TcdA and TcdB toxins are 
encoded by separate genes and share both sequence (66%) and structural 
similarity. The mechanism of action for both toxins is similar [13]. The CROP 
domain binds to receptors on the target cell (TcdA binds to carbohydrates on the 
apical surface of epithelial cells while TcdB binds to poliovirus receptor-like 3 
and Wnt receptor frizzled family (FZDs) on colonic epithelial cells) which triggers 
endocytosis [17]. In the endosome, the pH decreases during maturation, 
3 
triggering the insertion of the translocation domain, giving the GTD access to the 
host cytosol.  Using inositol hexakisphosphate as a cofactor, the cysteine 
protease domain cleaves the GTD from the rest of the protein.  Using UDP-
glucose, the GTD glucosylates Rho-family of GTPases which inactivates them 
[11-13, 18].  Inactivation of the Rho-family of GTPases leads to cell rounding, 
loss of colonic barrier function and eventual cell death [13].  
Though C. difficile growth occurs in the large intestine, exiting the body 
during the resulting diarrhea is fatal to the strictly anaerobic vegetative cells due 
to the presence of oxygen. Thus, to transit between hosts, C. difficile must 
survive the exposure to oxygen and to do this, C. difficile vegetative cells 
produce endospores. Endospores are dormant forms of bacteria that, in addition 
to being oxygen resistant, are resistant to UV radiation, high temperature (>60 
°C), desiccation, lysozyme activity, and detergents [19-22].   
Spore formation 
Endospores are formed in response to a developmental program whereby 
a vegetative cell places a septum that asymmetrically divides the cell into two 
compartments. To ensure that this process does not occur during log-phase 
growth, when nutrients are plentiful, the master transcriptional regulator of spore 
formation (Spo0A) in all studied endospore-forming organisms must be 
phosphorylated for its activity [23, 24]. Transcription of Spo0A is under the 
control of sigma H (σH), a post-exponential growth phase, alternative sigma 
factor that stimulates production of early sporulation proteins, including KinA and 
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Spo0E [25, 26]. In Bacillus subtilis, a phosphorelay signaling pathway controls 
the activation of Spo0A by phosphorylation (Figure 1) [23].  Embedded in the 
plasma membrane are kinases that lead to the activation of Spo0A. Either KinA 
or KinB phosphorylate Spo0F (Spo0F~P) [26, 27]. Spo0F~P transfers the 
phosphate to Spo0B and Spo0B~P then transfers the phosphate to Spo0A. 
There are reports that Spo0A is directly phosphorylated by KinC, but this has 
only been reproduced in mutants lacking both KinA and KinB and containing 
point mutations in Spo0A [26, 27]. Spo0E and KinD act to inhibit Spo0A 
phosphorylation. Interestingly, the abundance of Spo0A~P in the cell leads to 
differences in transcriptional activity.  At low Spo0A~P levels, biofilm formation is 
activated. However, as Spo0A~P levels increase, sirA (sporulation inhibitor of 
replication A) transcription is initiated [28]. SirA binds directly to the origin of 
replication, displacing the replication initiation factor DnaA, preventing the cell 
from undergoing further replication events [26]. At this point, SpoIIE is produced, 
which drives, through an unknown mechanism, the relocation of FtsZ to a polar 
septum [29]. The polar septum divides the cell into two unequally sized 
compartments: the larger will eventually become the mother cell and the smaller 
will become the forespore. Following asymmetric division, SpoIIE then 
dephosphorylates SpoIIAA [26, 30]. Dephosphorylated SpoIIAA (an anti-anti-
sigma factor) binds and sequesters SpoIIAB (an anti-sigma factor), relieving 
inhibition of SigF (σF), the early forespore-specific RNA polymerase sigma factor 
[26, 30]. After activation, σF recruits RNA polymerase to the spoIIR promoter to 
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promote expression of the spoIIR gene [26, 31]. SpoIIR is then secreted into the 
intermembrane space of the septum separating the mother cell and forespore, 
where it activates a protease, SpoIIGA [26]. Activated SpoIIGA cleaves the first 
mother cell sporulation-specific RNA polymerase sigma factor, SigE (σE), from 
pro-σE to its active form [26].  
In a phagocytic-like event, proteins whose expression is controlled by σE, 
initiate forespore engulfment by the mother cell. Though there are several 
proteins involved in the engulfment process, SpoIIIAH and SpoIIQ (both under 
σE control) are important components.  These two proteins interact and act, in a 
“ratchet-like” fashion, to draw the mother cell membrane over the forming 
endospore [32]. Forward movement around the forespore is due to random 
thermal motion but these two proteins prohibit reversal during engulfment. Upon 
the completion of engulfment, levels of SpoIIQ and SpoIIIAA-AH increase, 
forming a bridge between the mother cell and the forespore compartments 
(“feeding tube”) [33, 34]. Subsequently, σF activates σG expression within the 
forespore [34]. This potentially occurs through a metabolic limitation that 
presents in the newly-engulfed forespore [34-36] . σG activity leads to the 
expression of late-stage sporulation proteins within the endospore and the 
activation of σK within the mother cell [26, 37, 38]. σG is required to drive the 
expression of the proteins necessary for packaging dipicolinic acid (DPA), small 
acid-soluble protein expression and otherwise preparing the forespore for 
dormancy. σK activity is required to drive the expression of the proteins 
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necessary for formation of cortex peptidoglycan, coat proteins and, in some 
spore-forming bacteria, the exosporium [26]. 
Figure 1. Phosphorylation of Spo0A. 
Spo0A is phosphorylated through a cascade beginning with the phosphorylation 
of Spo0F by either KinA or KinB. Spo0F~P then phosphorylates Spo0B which 
phosphorylates Spo0A. Either Spo0E or KinD can inhibit the phosphorylation of 
Spo0A. At low levels, Spo0A drives biofilm formation; at high levels it initiates 
SirA transcription, which inhibits DNA replication. 
Formation of the spore coat depends upon SpoVM. SpoVM detects the 
difference between the outer forespore membrane and the inner mother cell 
membrane by detecting the difference in curvature [39, 40]. Once attached to 
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the membrane, SpoVM functions as an anchor for SpoIVA [41]. SpoIVA 
hydrolyzes ATP to drive self-assembly and functions as a scaffold on to which 
the mother cell-derived coat proteins are deposited [39, 42]. One coat protein, 
CmpA, has been shown to prevent cortex peptidoglycan assembly. SpoVM and 
SpoIVA repress CmpA, so as spore coat assembly proteins reach the highest 
concentrations, cortex assembly is derepressed [26].  
 Cortex formation begins with peptidoglycan (PG) synthesis, an important 
component of both vegetative cells and spores [43]. PG gives a vegetative cell 
its strength but is not responsible for the shape of the cell [26]. Cell wall PG is 
found in both the vegetative cell and the germ cell wall (GCW) of the endospore. 
The GCW is the precursor of what will become the cell wall of the vegetative cell 
[26].  Cell wall PG is composed of repeating subunits in an alternating 
configuration of N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM) 
residues. The stem peptides are attached to the lactyl groups of the NAM 
residues via their N-terminal linkage and are, generally composed of (Nterm)-L-
alanine – D-glutamate – meso-diaminopimeliate – D-alanine – D-alanine-
(Cterm). The terminal D-alanine is cleaved during crosslinking of the 4th amino 
acid (D-alanine) to the meso-diaminopimeliate of a neighboring glycan strand 
[26].  
Though it is also composed of peptidoglycan subunits, cortex PG is 
unique. Approximately 50% of the NAM residues found in the cortex PG have 
had their stem peptide removed which results in a decreased amount of 
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crosslinks and allows for the formation of muramic-δ-lactam residues [44]. 
Originally, this reduced level of crosslinking was hypothesized to allow the cortex 
to constrict and expand around the core of the spore, granting increased 
resistance. However, this hypothesis has been disproven. When the amount of 
cortex crosslinking is artificially increased to the level found in the GCW, there 
are no effects on the spore’s resistance properties [26]. The ability to form 
muramic-δ-lactam residues has also been removed, and while this did not have 
a measurable effect on any resistance properties, it did result in spores with a 
>104 decrease in the ability to form viable colonies [45, 46]. The muramic-δ-
lactam residues are the targets of spore cortex lytic enzymes (SCLEs), allowing 
the germinating spore to accurately target the cortex for degradation without 
degrading the GCW PG [45, 47]. Thus, the decrease in colony forming units 
observed in mutant (above) was presumably due to the inability of the spore to 
efficiently degrade cortex. Though the cortex is critical for dormancy, wet heat 
protection and protection against desiccation, there are no protective properties 
currently associated with the GCW [26, 48].  
Located underneath the cortex and GCW is the inner spore membrane 
where, in most spore-forming bacteria, many germination specific proteins are 
located (e.g. Ger-type, germinant receptors and proteins important for the 
packaging and release of DPA, see below). Though the inner membrane is a 
lipid bilayer, it is relatively impermeable when compared to the plasma 
membrane of vegetative cells [43]. One hypothesis for this lower permeability is 
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that the membrane is compressed by the cortex, and that cortex degradation 
permits the membrane to expand, thereby relaxing permeability. Also, the inner 
membrane is not nearly as fluid as what is found in vegetative cells, possibly due 
to the low water content of the spore’s core [49].  
 The spore core is at the center of the spore and is where the genomic 
DNA, RNA, ribosomes and many enzymes are located. Whereas the vegetative 
cell is ~88% water, the core has low water content, with water only accounting 
for ~28-57% of the wet weight [49]. Enriched within the core (~5 – 20% of the 
dry weight) is DPA and, mostly, is present as a 1:1 chelate with Ca2+. DPA is an 
important spore component which provides the heat resistance commonly 
associated with spore dormancy and a small amount of resistance against 
ionizing radiation [48]. In B. subtilis, DPA synthesis is controlled by the spoVF 
divergon (composed of the divergently-transcribed spoVFAB, asd, dapG and 
dapA operons) [49, 50]. spoVFAB expression is under σK control , thus DPA is 
synthesized in the mother cell during later stages of spore formation [51]. DPA is 
then packaged into the forespore by the forespore-encoded, DPA-binding 
protein, SpoVAD. By an unknown mechanism, SpoVAD packages DPA using 
the SpoVAC channel, rather than the feeding tube (SpoVAC-defective spores 
are severely DPA deficient) [52-54]. SpoVAA, SpoVAB and SpoVAEb, are also 
essential for DPA packaging and spore maturation, though their exact roles are 
not determined [55]. 
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Protecting the DNA against UV radiation and H2O2 are small acid soluble 
proteins (SASPs) that make up between 5 – 15% of the protein content of the 
dormant spore [26]. α, β and γ SASPs are encoded by ssp genes (sspA, sspB 
and sspE respectively) [56]. The α and β SASPs confer resistance to toxic 
chemicals and UV radiation [57, 58]. Their binding to DNA also helps to prevent 
transcription during dormancy. The third SASP, γ, does not appear to have DNA 
binding capability or confer any resistance properties [56]. During germination, 
the SASPs are degraded by Gpr, an aspartic acid protease. The degradation of 
the SASPs free the DNA to allow for transcription to resume and to provide a 
pool of amino acids for protein synthesis [26]. Gpr is produced as a zymogen 
during spore formation and activated through autocleavage just prior to spore 
dormancy. It is unable to cleave its substrates until core hydration during 
germination is complete [59].  
Interestingly, the mechanisms of spore formation in C. difficile exhibit 
significant departures from the B. subtilis model. The signal for initiating spore 
formation in C. difficile is currently unknown. Similar to B. subtilis, Spo0A is the 
master sporulation regulator but there is no phosphorelay system that 
phosphorylates Spo0A to its active form [60].  Several orphan histidine kinases 
are able to directly phosphorylate Spo0A but how this process is regulated 
remains unknown. One trigger of sporulation in C. difficile is associated with 
nutrient availability, and several proteins whose functions are associated with 
metabolism act as repressors of sporulation[3]. For example, Opp and App are 
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two peptide transporters that inhibit spore formation by an unknown mechanism 
[61]. CodY, a transcriptional regulator that responds to the abundance of 
branched chain amino acids and GTP, also to suppresses sporulation when 
nutrients are abundant [62]. Inactivation of opp, app or codY increase 
sporulation frequency [61, 62]. 
Predivisional C. difficile cells express three sporulation-associated 
proteins, SpoIIAB, SpoIIAA and SpoIIE [3, 30, 63]. These proteins appear to be 
involved in early septum formation at the start of asymmetric division. After the 
septum formation, the expression of σF and σE begins in the forespore and 
mother cell compartments, respectively [64]. In C. difficile, σE expression is 
under partial control of σF rather than under full control – it can be activated in 
the absence of σF [65]. Independent of both σE activity and engulfment, σG is 
activated in the forespore through an unknown post-translational mechanism [3]. 
In the mother cell, σK is expressed in its active form, not in the pro-form 
observed in other organisms, and C. difficile does not encode a SpoIVFB 
orthologue which processes pro-σK to the active form [65]. Cortex formation 
requires σG rather than σK (σK-mutant spores still assemble cortex) [64]. This 
leads to a sigma factor cascade model that diverges at the beginning of spore 
formation and proceeds independently of what occurs in the other 
compartments. The B. subtilis model of spore formation depends on crosstalk 
between the forespore and the mother cell, while C. difficile appears to have a 
significantly reduced level of cross-talk.  
12 
Spore germination 
The nature of a metabolically-dormant spore requires that the processes 
occurring during germination (i.e., degradation of SASPs, DPA release, cortex 
degradation) occur in an energy independent manner.  As a result, the initiation 
of germination and loss of spore dormancy must be pre-programmed (i.e., 
enzymatic). B. subtilis has been a model for spore germination and most spore-
formers have orthologues of germination-related proteins found in B. subtilis. 
Germination in B. subtilis, and all studied spore-forming bacteria, begins with a 
germinant binding to the germinant receptor [66]. Germinants are small 
molecules, most commonly nutrients, which bind to their cognate germinant 
receptor to trigger germination. In B. subtilis, germination is triggered by either L-
alanine or a mixture of L-asparagine, glucose, fructose and K+ ions (AGFK) [67]. 
The receptors are encoded by three homologous tricistronic operons, gerA, 
gerB, and gerK [66, 68, 69]. The GerA receptor (composed of the GerAA, GerAB 
& GerAC proteins) recognizes L-alanine, while the combined actions of the GerB 
and GerK (composed of the GerBA, GerBB & GerBC and GerKA, GerKB & 
GerKC proteins, respectively) receptors recognize AGFK [66, 70].  
Following germinant binding, cations are released, followed by release of 
DPA from the spore core. The release of DPA is associated with the proteins 
encoded by the spoVA operon (spoVAA, spoVAB, spoVAC, spoVAD, spoVAEa, 
spoVAEB, spoVAF) (Figure 2) [54]. The functions of many of these proteins are 
unknown, however most are essential for DPA packaging or release during 
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spore formation and germination, respectively [52, 71, 72]. However, SpoVAD 
was shown to bind to DPA and SpoVAC has mechanosensing properties and is 
associated with DPA release [53, 54]. SpoVAEa and SpoVAF are non-essential 
for spore germination. spoVAEa and spoVAF mutants germinate but germination 
occurs at a slower rate [55]. The release of cations and DPA from the spore 
completes Stage I of spore germination [66].  
Figure 2. B. subtilis spoVA operon 
In B. subtilis, the release of DPA from the core activates Stage II of 
germination. Stage II consists of cortex degradation, complete core hydration 
and expansion and loss of the resistance properties normally associated with 
dormancy (e.g., heat resistance) [66]. In B. subtilis, cortex degradation is 
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controlled by two SCLEs, CwlJ and SleB. Spores can degrade their cortex using 
either enzyme but germination by B. subtilis ΔcwlJ ΔsleB spores cannot proceed 
past Stage I of germination [73]. Both enzymes target the muramic-δ-lactam 
residues of the cortex peptidoglycan, with SleB acting as a lytic transglycosylase 
[73]. SleB is synthesized in the fore-spore and localizes to the inner spore 
membrane, just outside the core. Conversely, CwlJ is synthesized in the mother 
cell and is hypothesized to be localized to the spore coat, though the location of 
the protein in the spore and its mechanism of action has not been adequately 
determined [74, 75]. 
The activities of these SCLEs must be regulated in a way that prevents 
their activity during dormancy.  SleB activity is inhibited by YpeB, which is 
degraded after germination begins, thereby allowing SleB access to the cortex 
PG [73].  CwlJ is activated by the DPA that is released from the spore core and 
exogenous DPA also can trigger CwlJ activity [75]. With the cortex degraded, 
the core is able to continue to rehydrate and expand. This stage of reactivation 
and resumption of protein synthesis is termed ‘ripening’ [66]. The spore has a 
limited supply of stored ATP, so the energy required for this stage is provided by 
metabolizing 3-phosphoglyceric acid (PGA).  PGA is an acid-soluble spore 
phosphorous compound that is an intermediate in both the Calvin cycle and 
glycolysis and functions as a stable energy reservoir for the spore [76].  
 Spore germination in most of the identified spore-forming bacteria is most 
similar to what is observed for B. subtilis with the major variation being 
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differences in what germinants activate the process. However, a few identified 
bacteria form spores and germinate by novel methods, including Clostridium 
perfringens and C. difficile.  C. perfringens is an anaerobic spore forming 
bacteria that inhabits the soil and intestines of humans and animals, and is the 
causative agent of clostridial myonecrosis (gas gangrene) and mild 
enterotoxemia [77].  
 Germination in C. perfringens differs from B. subtilis with the products of 
the gerK operon serving as the primary germinant receptors [78]. The operons 
are organized into two separate transcriptional units, the monocistronic gerKB 
gene and the bicistronic gerKA-KC genes [79]. GerKA and GerKC are required 
for L-asparagine and KCl-mediated germination. Though GerKB is important for 
germination, it appears to not play a direct role in germinant detection [79]. 
Rather is required for spore viability and outgrowth. Though C. perfringens 
encodes a potential gerA ortholog, it has little effect on germination.  In another 
departure from the mechanisms of germination found in B. subtilis, C. 
perfringens does not encode any B. subitilis SCLEs orthologues. C. perfringens 
encodes sleC and sleM [80, 81]. SleC acts on intact spore cortex and is an N-
acetylmuramyl-L-alanine amidase [81]. SleM is an N-acetylmuramidase and acts 
on disrupted peptidoglycan fragments following SleC degradation [80].  Both 
enzymes are localized outside of the spore cortex layer, but only SleC is 
essential for germination.  
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Similar to what is observed in B. subtilis, the SCLE activities in C. 
perfringens must be regulated to prevent premature cortex degradation.  To 
prevent such an occurrence, SleC is deposited into the C. perfringens spore as 
a zymogen, pro-SleC [82]. To generate active SleC enzyme, the pro-sequence 
must be removed, and this occurs early during germination by a group of 
germination-specific, subtilisin-like, serine proteases – the Csp proteins. Many 
C. perfringens strains encode three Csp proteases, cspA, cspB and cspC [82,
83]. All three of these proteases are capable of cleaving pro-SleC in vitro. C. 
perfringens strain SM101 only encodes one active protease, CspB, and is it 
essential for cortex hydrolysis and rapid DPA release. Thus, this presents a 
different model of spore germination, when compared B. subtilis, wherein DPA 
release from the core may not directly activate SCLEs.  Rather the Csp 
protein(s) are activated, by an unknown mechanism, to cleave the SCLEs and 
initiate cortex degradation.  
C. difficile spore formation and germination
Germination by C. difficile spores is initiated by a combination of certain 
bile acids and amino acids (glycine has highest efficiency in laboratory 
conditions) [84, 85]. Bile acids are synthesized in liver hepatocytes using 
cholesterol as a precursor and secreted into the gut to aid in the absorption of 
fats during digestion. Humans produce two primary bile acids, cholic acid (CA) 
and chenodeoxycholic acid (CDCA), while rodents produce other bile acids 
(muricholic acids, see Chapter II and Figure 3) in greater amounts than CDCA 
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[86-88]. These primary bile acids are then modified through conjugation with 
either a taurine [producing taurocholic acid (TA) or taurochendeoxycholic acid] 
or glycine (producing glycocholic acid or glycochenodeoxycholic acid) at the C-
24 carboxyl group [88]. During digestion, the bile acids aid traffic through the 
small intestine and most are reabsorbed and recycled to the liver to be used in 
other rounds of digestion [89]. Though efficient, enterohepatic recirculation is not 
100%. Approximately 5 – 10% of the total bile acid pool escapes this process 
and enters the large intestine where it becomes modified by the resident 
microbiome [90]. 
Many members of the colonic microbiome express on their cell surfaces 
bile salt hydrolases, Bsh, that cleave the conjugated taurine or glycine from the 
base CA or CDCA structures (deconjugation) [88]. Subsequently, specific 
bacteria in the microbiome actively take up the deconjugated CA and CDCA and 
convert them to deoxycholic acid (DCA) and CDCA to lithocholic acid (LCA), 
respectively [88].  This 7α-dehydroxylation reaction proceeds to completion in a 
heathy gut (primary bile acids are not found in a healthy gut – they are 
metabolized to secondary bile acids). The presence and concentrations of these 
different bile acids can impact the gut microbiome potentially due to their 
detergent-like effects. How bile acids induce bacterial cell death is not currently 
known, but it has been suggested that the presence of bile acids may elicit 
stress response membrane synthesis and protection or trigger various DNA 
repair pathways [91-93]. Because bile acids can be potentially toxic to bacteria, 
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different mechanisms have been developed to tolerate or alter what bile acids 
are present. Whereas some bacteria modify bile acids (e.g., 7α-
dehydroxylation), many have export mechanisms for expelling bile acids [94].  
Figure 3. Bile acid synthesis and conversion 
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For C. difficile, CDCA, LCA and DCA are toxic to vegetative cells, though 
the mechanism of toxicity is unknown. Whereas, C. difficile spores recognize CA 
and its derivatives (including DCA) as germinants, CDCA-derivatives act as 
inhibitors of CA-mediated germination [84, 85, 95, 96].  In our working model, 
ingested C. difficile spores encounter approximately equal ratios of CA- and 
CDCA-derivatives in the host’s small intestine. Under these conditions, 
germination would be inhibited because the C. difficile spore interacts with 
CDCA with greater apparent affinity [96]. Thus, germination would be blocked in 
the aerobic environment of the small intestine.  In the anaerobic environment of 
the colon, however, CDCA is passively absorbed by the colonic epithelium at a 
ten-times greater rate than CA [89]. Thus, in the antibiotic-treated colon, the ratio 
of CA to CDCA shifts towards CA and, thus, germination-promoting conditions. 
Though the signals that stimulate germination are known, with what the 
germinants interact was originally unknown. This was largely due to the absence 
of ger-type orthologues in the C. difficile genome [97].  
Using a chemical mutagenesis screen to identify candidate genes, our 
laboratory demonstrated that a homolog of C. perfringens CspC is the C. difficile 
bile acid germinant receptor [98]. Though they are homologous, there are 
several important differences between the Csp proteins found in C. difficile and 
C. perfringens. In C. difficile, the csp operon that encodes cspC also encodes
cspB and cspA. However, unlike what is observed in C. perfringens, C. difficile 
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cspB and cspA are translationally fused and generate CspBA that is then 
cleaved to CspB and CspA, presumably by the YabG protease [99]. During 
germination and following the germinant / germinant receptor interaction, the C. 
difficile cortex hydrolase, SleC, must be cleaved from its inactive pro-form by the 
Csp proteins. Importantly, C. difficile CspA and CspC are catalytically inactive 
pseudoproteases (they lack the catalytic triad necessary for activity), and are 
unable to cleave the pro-SleC to its active form [99]. However, C. difficile CspB 
contains an active catalytic triad and has the potential to process pro-SleC. In 
our working model, we hypothesize that that CspC binds to the bile acid 
germinant and, through an unknown mechanism, triggers CspB to cleave pro-
SleC into SleC [98]. How and where the amino acid co-germinant binds is 
currently unknown. 
 Another important regulator of C. difficile spore germination is GerS [100]. 
GerS is synthesized in the mother cell under σE control and appears to localize 
to the inner leaflet of the outer spore membrane. Here, it is hypothesized to act 
as an anchor for other germination proteins (e.g., CspA, CspB, CspC and pro-
SleC). During germination, C. difficile ΔgerS spores process the germinant 
signal and cleave pro-SleC into SleC [100]. Though processed to an active form, 
SleC does not degrade cortex suggesting that GerS may help to release active 
SleC from the complex. Supporting this idea is recent data showing that along 
with acting as the germinant receptor, CspC also appears to have an inhibitory 
effect on germination [101].  
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The model for C. difficile spore germination has presented (Figure 4) 
several interesting deviations from what is observed for B. subtilis spore 
germination. One of the first departures from the mechanisms of spore 
germination found in B. subtilis (and C. perfringens) was that the germinant 
receptor appears to be located in the cortex [66, 98]. In our working model for C. 
difficile spore germination, we proposed that CspC activates the CspB protease 
which then cleaves SleC to its active form.  This model would suggest that 
germinant binding could lead to cortex hydrolysis and then DPA release, 
opposite to what has been observed for B. subtilis and all other spore-forming 
bacteria studied to date. If cortex hydrolysis occurs before DPA release, how is 
DPA release initiated? In the following chapters, we will discuss how we 
determine when spore cortex hydrolysis occurs and potentially how DPA is 
released.  
Figure 4. Model for C. difficile germination 
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CHAPTER II 
 MURICHOLIC ACIDS INHIBIT CLOSTRIDIUM DIFFICILE SPORE 
GERMINATION AND GROWTH* 
In Chapter II, we analyze the effects of mouse-derived bile acids 
(muricholic acids) on the germination of C. difficile spores. These bile acids, α, β 
and ω muricholic acids, were tested for both their effects on spore germination 
and vegetative growth using two C. difficile strains.  
Introduction 
Clostridium difficile is an anaerobic, spore-forming bacteria that is the 
leading cause of antibiotic-associated diarrhea. As the costs associated with 
treatment continue to rise [102, 103], much research has focused on 
understanding the normal course of infection within humans. One of the 
challenges in the study of C. difficile infections has been developing suitable 
animal models that adequately reproduce symptoms as presented in humans. 
Gnotobiotic neonatal piglets, rats, and germ-free mice have all been used to 
varying degrees of success [104-107]. The most widely used model has been 
the Syrian hamster model of C. difficile disease [5, 108-111]. Antibiotic-treated 
hamsters are very sensitive to C. difficile infection with lethal disease presenting 
approximately 3 days after inoculation by C. difficile spores.  While the hamster 
* Reprinted with permission from “Muricholic acids inhibit Clostridium difficile spore
germination and growth” Francis, MB., Allen, CA., Sorg, JA. PLoS ONE. 2013 Sep 9;8(9): 
e73653 doi: 10.1371/journal.pone.0073653. 
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represents an excellent model of acute disease, hamsters typically succumb too 
quickly to disease to measure factors influencing colonization, representing only 
the full presentation of disease and not less severe symptoms when exposed to 
epidemic strains [112]. Such rapid progression of the disease and high mortality 
can also pose problems when attempting to study relapsing infection. 
 Several mouse models of infection have been developed [106, 113-117].  
Some of these models use heavy doses of antibiotics (e.g. kanamycin, 
gentamicin, colistin, metronidazole and vancomycin followed by clindamycin or 
cefoperazone followed by clindamycin) and then inoculation with C. difficile 
spores or vegetative cells [114, 115].  These antibiotic regimens sensitize mice 
so that they respond to infection in a dose dependent manner (increasing 
disease severity with increasing number of dosed cells or spores). Further, 
antibiotic-treated mice can relapse after a course of antibiotic treatment, to cure 
the primary infection, and will express some resistance to reinfection when 
allowed to fully recover from disease [114]. These are important components of 
an animal model because relapse in humans represents one of the main 
challenges to current treatment regimens [118, 119]. 
 Because the mouse model is beginning to be a more widely accepted 
method of testing potential preventative therapies [120] and the genetic 
requirements for infection [113, 121, 122], it is important to understand what 
potential variability exists between the mouse model of infection and humans. 
One potential source of variability is the natural differences between mouse and 
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human microbiota. The use of an antibiotic cocktail before infection is an attempt 
to impact these other microbes [123, 124]. Another important source of 
variability is the differences in the natural fecal bile acid composition between 
mice [86, 125] and humans [88] (and hamsters [126-128]).  
 In humans, bile acids are synthesized in the liver as either cholic acid (3α, 
7α, 12α-trihydroxy-5β-cholanic acid) or chenodeoxycholic acid [3α, 7α,-
dihydroxy-5β-cholanic acid (CDCA)] [88]. These bile acids are then conjugated 
with either taurine or glycine and, later, further modified by certain members of 
the colonic microbiota [88]. Previous work has shown that colony formation by C. 
difficile spores on rich medium occurs after exposure to cholic acid derivatives 
[84, 85].  Subsequent work has shown that all cholic acid derivatives and some 
amino acids, commonly glycine, can stimulate the initiation of spore germination 
while CDCA-derivatives are competitive inhibitors of cholic acid-mediated 
germination [85, 95, 96, 129, 130]. In mice and rats, CDCA is a component of 
bile, but there are two additional bile acids, α-muricholic acid (AMA) and β-
muricholic acid (BMA), that are not present in humans [89].  A third muricholic 
acid, ω-muricholic acid (OMA), is an epimer of BMA and is produced by the 
normal microbiota.  The effects of these compounds on C. difficile spore 
germination are unknown. 
 Germination by C. difficile spores must be the first step in colonization 
[98, 120].  The toxins necessary for disease are not found within the spore or 
deposited on the outer layers during spore formation [131].  To generate active 
infection in the hamster model of C. difficile disease, approximately 100 spores 
will result in a lethal infection (LD100) while in the mouse model, significantly 
more spores are required to generate lethal disease (~108) [120].  Interestingly, 
when vegetative cells are used to inoculate antibiotic-treated mice, fewer cells 
are needed (~105), suggesting the efficiency of in vivo germination by C. difficile 
spores may be affected differently in the mouse than in the hamster [114, 120, 
132]. 
Here, we investigate how muricholic acids affect C. difficile spore 
germination and growth using two C. difficile isolates; UK1 – an epidemic 
ribotype 027 isolate [96, 133]  and M68 – a ribotype 017 that readily colonizes 
mice [113, 117].  We find that all three muricholic acids can inhibit C. difficile 
spore germination with apparent affinities similar to what is observed for CDCA 
and that these compounds are also growth inhibitory.  
Materials and methods 
C. difﬁcile growth conditions
C. difﬁcile strain UK1 [96, 98, 133, 134] and strain M68 [113, 135] were
grown in BHIS medium (Brain Heart Infusion supplemented with 5 g / L yeast 
extract and 0.1% L-cysteine) at 37 °C in an anaerobic environment (85% 
nitrogen, 10% hydrogen and 5% carbon dioxide). 
C. difficile spore preparations
Spores of C. difficile UK1 and C. difficile M68 were prepared as described 
previously [96, 134, 135].  Briefly, C. difﬁcile UK1 or M68 were streaked on BHIS 
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agar medium and incubated for 4 days under anaerobic conditions at 37 °C. 
Plates were then removed from the chamber and cell matter was scraped and 
diluted into 1 mL of water. Tubes were then left to incubate overnight at 4 °C to 
aid in the release of spores from the mother cell. The next day, cell matter was 
resuspended and centrifuged at 14,000 x g for 1 minute. Tubes were decanted 
and resuspended in 1 mL of water. After 5 washes, the pellets from several 
tubes were combined in 2 mL water and layered on top of 8 mL of 50% sucrose. 
Spores were separated from vegetative cells and cell debris by centrifugation for 
20 minutes at 4,000 x g. All liquid was then removed from the tube.  The pellet, 
containing the purified spores, was resuspended in 1 mL of water. The purified 
spores were washed in water as described above. When examined by phase-
contrast microscopy, the remaining pellet appeared to be composed >99.9% 
phase-bright spores. 
Germination of C. difficile spores 
 Puriﬁed spores were heat activated for 30 min at 65 °C and placed on 
ice, as described previously [95, 96, 134, 136, 137]. Heat-activated spores were 
then diluted into 990 μL BHIS supplemented with 0 mM, 2 mM, 5 mM, 10 mM, 
20 mM or 50 mM taurocholate. When testing muricholic acids or CDCA, bile 
compound was added to tubes before the addition of spores. The initiation of 
germination was followed by monitoring absorbance at 600nm.  The ratio of the 
A600 at time X (Tx) to the A600 at time zero (T0) was plotted against time. 
Germination rates, and apparent affinities, were determined using the slopes of 
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the linear portions of the germination plots, as described previously [96, 134, 
137]. Data are reported as the averages from three independent experiments 
with one standard deviation from the mean.  For clarity, only every fourth data 
point is plotted.   CDCA, AMA, BMA and OMA were dissolved at 100 mM in 
100% ethanol.  AMA, BMA and OMA were purchased from Steraloids, Inc 
(Newport, RI). 
Minimum inhibitory concentration 
C. difficile, from an actively growing plate, was grown overnight in 5 mL
liquid BHIS under anaerobic conditions.  The next day, 25 mL BHIS medium was 
inoculated with 0.25 mL of the overnight C. difficile culture and then incubated 
until an OD600 of 0.45. One hundred twenty five-microliters of this culture then 
added to 50 mL of ice cold reduced BHIS and kept on ice.  Microtiter plates 
containing BHIS and serially diluted compound were previously prepared and 
placed in anaerobic chamber to reduce.  10 µL of chilled cells were then added 
to wells and incubated for 24 hours at 37°C.  After 24 hours, plates were 
removed from the anaerobic chamber and growth measured using a BioRad 
Xmark plate reader. 
Statistical significance 
Experiments were performed in triplicate and data represent the average 
of the three independent experiments.  Statistical significance between UK1 and 
M68 was determined using the Student’s T-test. 
Results 
Structures of muricholic acids 
Mice synthesize three bile acids not found in humans.  Two of these 
compounds are synthesized directly by the mouse; AMA (3α, 6β, 7α-trihydroxy-
5β-cholanic acid) and BMA (3α, 6β, 7β-trihydroxy-5β-cholanic acid) (Figure 5) 
[86, 125].  The third muricholic acid, OMA (3α, 6α, 7β-trihydroxy-5β-cholanic 
acid) is produced by oxidation of the 6β-hydroxyl of β-muricholic acid followed by 
reduction of the compound to a 6α-hydroxyl group (Figure 5) by members of the 
mouse colonic microbiota [138, 139].  
AMA and BMA contain a 6β-hydroxyl group while OMA contains a 6α-
hydroxyl group (Figure 5).  The conformational effect of this 6-hydroxyl group is 
untested on C. difficile spore germination because bile acids normally found in 
the human gut lack the 6-hydroxyl group.  As shown in Figure 5, all three 
muricholic acids lack a 12α-hydroxyl group, suggesting they might act as 
inhibitors of C. difficile spore germination [96].  
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Figure 5. Structures of common muricholic acids. 
The primary bile acids (cholic acid, chenodeoxycholic acid, α-muricholic acid 
and β-muricholic acid) are listed.  Deoxycholic acid and ω-muricholic acid are 
secondary bile acids and are products of the normal microbiota. 
Muricholic acids inhibit C. difficile spore germination 
To understand how these compounds affect germination, C. difficile 
spores were assayed for germination in the presence or absence of muricholic 
acids.  As positive and negative controls, respectively, the initiation of spore 
germination was followed in the presence of taurocholic acid, a known C. difficile 
spore germinant [84, 85] or in the presence of taurocholic acid and CDCA, a 
known inhibitor of C. difficile spore germination [95, 96].  
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Figure 6. α-muricholic acid inhibits germination by C. difficile UK1 spores. 
(A) Germination of Clostridium difficile UK1 spores in complex medium 
supplemented with taurocholic acid (TA) or (B) medium supplemented with TA 
and 1 mM CDCA or (C) medium supplemented with TA and 1 mM α-muricholic 
acid. ● 0 mM TA,  2 mM TA,  5 mM TA,  10 mM TA, 20 mM TA or ○ 50 
mM TA. (D) The inverse rate (1/v [sec/OD600]), versus the inverse taurocholate 
concentration (1/S [mM-1], was plotted. Apparent Km values for TA alone (●) and 
in the presence of α-muricholic acid () were determined from the linear best fit. 
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Purified C. difficile UK1 spores were suspended in BHIS medium and different 
taurocholic acid concentrations (Figure 6A).  As described previously, the rate of 
germination increased with increasing taurocholic acid concentration [96, 134, 
137].  The addition of 1 mM CDCA had an inhibitory effect on germination 
(Figure 6B).  The addition of 1 mM AMA resulted in a clear reduction of the 
ability of C. difficile spores to germinate in response to TA (Figure 6C).  The 
effect of this inhibition of germination was quantified by applying Michaelis-
Menten kinetics to the germination plots to generate apparent Km values.  While 
not traditional enzyme kinetics, these types of analyses have aided in the 
identification of the requirements for spore germination and for novel inhibitors of 
spore germination [96, 130, 134, 136, 137, 140, 141].  Analysis of the 
Lineweaver-Burk plot of C. difficile UK1 spore germination in taurocholic acid 
alone (Figure 6D) yielded an apparent Km value similar to what has been 
previously reported (Table 1) [96, 134].  When analyzing germination by C. 
difficile UK1 spores in the presence of different muricholic acids, it was 
immediately obvious that these compounds were germination-inhibitory.  From 
the germination plots, we determined the rates of germination and used this data 
to generate apparent inhibitory constants (Ki) for each inhibitor tested (Table 1).  
Comparing the muricholic acids to CDCA, BMA and OMA yielded apparent 
inhibition constants similar to CDCA while AMA proved to be least efficient at 
inhibiting germination (Table 1).  The difference between CDCA and AMA can 
be observed by comparing the ability of C. difficile spores to germinate in BHIS 
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medium supplemented with 2 mM TA.  Addition of 1 mM CDCA had a greater 
effect than did the addition of 1 mM AMA. 
 
 
 
Figure 7. α-muricholic acid inhibits germination by C. difficile M68 spores. 
(A) Germination of Clostridium difficile M68 spores in complex medium 
supplemented with taurocholic acid (TA) or (B) medium supplemented with TA  
and 1 mM α-muricholic acid. ● 0 mM TA,  2 mM TA,  5 mM TA,  10 mM 
TA, 20 mM TA or ○ 50 mM TA. (C) The inverse rate (1/v [sec/OD600]), versus 
the inverse taurocholate concentration (1/S [mM-1], was plotted. Apparent Km 
values for TA alone (●)  and in the presence of α-muricholic acid () were 
determined from the linear best fit of the plotted data.  (D) Hill Plot was 
generated to determine the apparent Km values for each condition.  
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 Germination of C. difficile M68 in medium with taurocholic acid was 
similar to C. difficile UK1. C. difficile M68 rapidly germinated in medium 
supplemented with taurocholic acid (Figure 7A) and was inhibited when 1 mM 
AMA was added to the germination solution (Figure 7B).  However, by analyzing 
the kinetics of C. difficile M68 spore germination, we observed that the data from 
this strain produced non-linear Lineweaver-Burk plots (Figure 7C), a 
phenomenon observed for some other C. difficile strains [137].  The Hill plot 
(Figure 7D) was used to generate the apparent Km. This value was then used to 
determine the apparent Ki under each condition tested.  When C. difficile M68 
spores were germinated in the presence of CDCA, germination was strongly 
inhibited (Table 1). The inhibition of germination by BMA was similar to the 
inhibition observed for C. difficile UK1 and, again, AMA was the least efficient at 
inhibiting spore germination (Table 1). OMA was a more potent inhibitor of C. 
difficile M68 spore germination than C. difficile UK1 spore germination (p-value < 
0.05). 
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Table 1. Bile acid effects on C. difficile spore germination 
Strain UK1 M68 
Km (mM) Km (mM) 
Taurocholic Acid 3.2 ± 0.5 3.5 ± 0.5 
Ki (mM) Ki (mM) 
Chenodeoxycholic Acid 0.22 ± 0.07 0.12 ±  0.02 
α-Muricholic Acid 0.62 ± 0.09 0.59 ± 0.05 
β-Muricholic Acid 0.27 ± 0.12 0.26 ± 0.02 
ω-Muricholic Acid 0.29 ± 0.03 0.20 ± 0.01* 
Ki = [inhibitor]/[(Km,TA with inhibitor)/((Km,TA without inhibitor)-1)] 
* p < 0.05
Minimum inhibitory concentration of muricholic bile acids 
 Previously, we demonstrated that CDCA and deoxycholic acid inhibited 
C. difficile growth [85].  In antibiotic-treated mice, the levels of deoxycholic acid
are likely to be very low because it is a product of the 7α-dehydroxylation of 
cholic acid by the normal microbiota [88].  However, cholic acid, CDCA, AMA 
and BMA will be present and could affect C. difficile growth.  To quantify the 
effects of these compounds on C. difficile growth, we determined the MIC.  
Serial, 2-fold dilutions of bile acids in growth media were used determine the 
MIC for each bile acid (Table 2).  C. difficile strain UK1 did not grow in the 
presence of CDCA or AMA or BMA, at a concentration of 1 mM or above. OMA 
was less toxic to the strain; a concentration of 2 mM was necessary to inhibit 
growth.  In stark contrast, the MIC of cholic acid for C. difficile UK1 was 10 mM, 
a concentration not found in the colon.   We observed slightly different results 
when analyzing the MIC of these bile acids for C. difficile M68 growth.  This 
strain was more resistant to the toxic effects of AMA and BMA while equally as 
sensitive to CDCA, cholic acid and deoxycholic acid (Table 2).  BMA is more 
prevalent in the gut of rats and mice than is CDCA [125], suggesting that a strain 
which is more resistant to the toxic effects of BMA (e.g. C. difficile M68) might be 
able to better colonize mice.  
Table 2. Minimum inhibitory concentration of bile acids for C. difficile strains 
Strain UK1 (mM) M68 (mM) 
Cholic Acid 10.0 ± 0.0 10.0 ± 0.0 
Deoxycholic Acid 1.0 ± 0.0 1.0 ± 0.0 
Chenodeoxycholic Acid 1.0 ± 0.0 1.0 ± 0.0 
α-Muricholic Acid* 1.0 ± 0.0 2.0 ± 0.0 
β-Muricholic Acid* 1.0 ± 0.0 2.0 ± 0.0 
ω-Muricholic Acid 2.0 ± 0.0 2.0 ± 0.0 
The MIC did not vary between experiments. 
*p < 0.01
Discussion 
In the laboratory setting, certain combinations of bile acids and amino 
acids are the most effective conditions for measuring C. difficile spore 
germination [84, 85, 129].  While cholic acid derivatives can stimulate C. difficile 
spore germination [85], CDCA-derivatives inhibit cholic acid-mediate germination 
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by C. difficile spores [95, 96]. Compared to humans, mice produce a low level of 
CDCA but produce other bile acids (AMA and BMA), in greater abundance.  
These muricholic acids may have an impact on how C. difficile spores germinate 
in vivo.  Here, we found that AMA, BMA and OMA (a microbial product) inhibit 
taurocholic acid-mediated spore germination with BMA and OMA being the most 
potent germination-inhibiting muricholic acids (Table 1). These results are 
consistent with our previous work that has shown the 12-hydroxyl group to be an 
important determinant of whether a compound functions as a germinant or 
inhibitor of germination [85, 95, 96].  One difference observed between the 
germination of C. difficile UK1 spores and C. difficile M68 spores was the non-
linear double-reciprocal plot for germination by C. difficile M68 spores.  As seen 
in other strains, C. difficile M68 may bind taurocholic acid cooperatively [137].  
With the recent identification of the molecular target of bile acids on the C. 
difficile spore, this hypothesis could be tested outright [98]. 
 Total bile acid levels in the distal small intestine have been estimated to 
be between 1 mM to 2 mM in concentration [142]. This is in the range of the 
concentrations which inhibit C. difficile growth for the individual bile acids tested 
(Table 2); variations in pH may affect the toxicity of each bile acid [143].  
Comparing these concentrations to the apparent Ki values determined for AMA 
and BMA, they are approximately 3x to 8x greater, respectively (Table 1).  That 
is, in an antibiotic-treated mouse, the levels of AMA and BMA might prevent 
efficient C. difficile spore germination, possibly explaining why such greater 
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numbers of spores, compared to vegetative cells, are required to colonize a 
mouse [120].  It is also important to note that most mice used as a model for C. 
difficile infection would likely contain reduced levels of OMA because its 
formation requires the presence of mouse gut microbes [138, 139] which are 
likely ‘collateral damage’ during a routine course of broad-spectrum antibiotics.   
 Antibiotics can affect host functions.  That is, treating mice with antibiotics 
could lead to alterations in the bile acid spectrum and increase or decrease the 
availability of activators or inhibitors of C. difficile spore germination.  Treatment 
of mice with antibiotics has been shown to increase hepatic bile acid synthesis 
[144].  Specifically, the authors identified that small intestine, lumenal 
concentrations of taurocholic acid, tauro-β-muricholic acid and 
taurochenodeoxycholic acid were more abundant in antibiotic-treated C57/BL6 
mice than in vehicle-only controls [144]; the authors did not measure the levels 
of AMA.  Thus, upon antibiotic exposure, an increase in the abundance of 
germination-inhibiting bile acids could contribute to an environment which is 
more resistant to C. difficile spore germination. 
 Some C. difficile strains have been shown to stably colonize mice and 
enter a ‘contagious’ state, where disease is limited but spore shedding is 
maintained, while other strains are cleared by the host [113, 117].   The 
mechanisms by which some C. difficile strains are able to stably colonize a host 
while others do not, is unclear.  While the answer is likely to be multifactorial, an 
increased resistance to bile acids could contribute to a strain’s ability to persist 
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within a host.  C. difficile M68 is a strain that can enter a supershedder state 
after the cessation of antibiotic treatment [113].  We find C. difficile M68 to be 
more resistant to bile acid toxicity than is C. difficile UK1 and this increased 
resistance may aid C. difficile M68 in maintaining active colonization. 
 Muricholic acids might provide a level of protection to mice from C. 
difficile infection that is not seen in other models of C. difficile disease. While our 
results suggest that particular bile acids may inhibit C. difficile spore germination 
or vegetative growth in vitro, it is unclear if AMA or BMA could substitute for 
each other in preventing in vivo spore germination.  Clearly, BMA is a more 
potent inhibitor of in vitro spore germination than is AMA.  But, given the vast 
repertoire of mouse lines and genetic approaches, testing the ability of C. difficile 
to colonize mice that have had introduced mutations into specific steps in the 
bile acid / muricholic acid synthesis pathway would allow the determination of 
which bile acids are relevant for stimulating or inhibiting in vivo spore 
germination and vegetative growth. 
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CHAPTER III 
SPORE CORTEX HYDROLYSIS PRECEDES DPA RELEASE DURING 
CLOSTRIDIUM DIFFICILE SPORE GERMINATION* 
In Chapter III, we analyze how C. difficile spore germination differs from 
what has been observed during B. subtilis spore germination, a model organism. 
In particular, we determine when DPA is released from germinating spores and 
how this event is timed with the degradation of the spore cortex layer. In all other 
spore-forming bacteria studied to date, DPA release during spore germination 
occurs following germinant-germinant receptor interaction and the release of 
DPA triggers cortex hydrolysis. Based on the proposed location of the C. difficile 
germinant receptor, CspC, we proposed to that cortex hydrolysis occurred prior 
to DPA release and find that this is indeed true.   
Introduction 
Clostridium difficile (a Gram-positive, spore-forming, strict anaerobe) has 
become a significant threat to antibiotic-treated or immunocompromised hosts.  
Antibiotics are known to disrupt the colonic microbiota and this perturbation 
permits C. difficile colonization [145, 146].  Due to the strict anaerobic nature of 
C. difficile cells, spores are generally thought to be the infectious agent (only the 
spore can survive for extended periods of time in the aerobic environment 
* Reprinted with permission from “Spore cortex hydrolysis precedes dipicolinic acid release
during Clostridium difficile spore germination” Francis, MB., Sorg, JA. J Bacteriol. 2015
Jul;197(14):2276-83. doi: 10.1128/JB.02575-14. Copyright © American Society for Microbiology
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outside of a host) [60, 147].  Because the spore form is non-infectious, spores 
must germinate to actively growing bacteria which initiate infection [98, 131].  
Thus, germination by C. difficile spores represents one of earliest steps in the 
pathogenesis of this organism. 
 Endospore germination has been extensively studied in Bacillus sp. and, 
more recently, in clostridia [66, 97].  In the spore core, small acid soluble 
proteins help protect the chromosomal DNA and much of the water is replaced 
by pyridine-2,6-dicarboxylic acid (dipicolinic acid) as a 1:1 chelate with calcium 
(CaDPA) – accounting for approximately 10% of the dry weight of the spore [66].  
Surrounding the spore core, is an inner spore membrane, a thin layer of cell wall 
peptidoglycan, a thick layer of specialized cortex peptidoglycan, an outer spore 
membrane and spore coat proteins.  These features help protect the spore from 
environmental hardship and help the spore remain in a metabolically dormant 
state [66].  Even though spores are metabolically dormant, they interact with the 
environment and germinate when conditions become favorable for vegetative 
growth. 
In B. subtilis, germinant receptor-mediated germination can be divided 
into two stages.  Stage I is triggered when germinant receptors embedded within 
the inner spore membrane respond to the presence of small molecule 
germinants [66].  The most often described germinants for B. subtilis spores are 
L-alanine (or L-valine) or a mixture of L-asparagine, glucose, fructose and 
potassium ions (AGFK) [66]. The interaction of L-alanine / valine with the 
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GerAA-AB-AC germinant receptor or AGFK with the GerB / GerK germinant 
receptor leads to the release of CaDPA from the core, likely through the SpoVA 
channel, in exchange for water [66].  The release of CaDPA from the core 
completes stage I. 
Stage II is activated by the release of CaDPA from the core during stage 
I, and stage II can be directly activated by an abundance of exogenous CaDPA 
(non-nutrient mediated spore germination) [66].  During stage II, cortex is 
degraded by the spore cortex lytic enzymes (SCLEs) CwlJ and SleB [66].  While 
the mechanism of activation of SleB is unknown, CwlJ activity is activated by 
DPA [66].  Thus, CaDPA release from the core stimulates cortex hydrolysis 
which leads to the swelling of the germ cell wall and core expansion.  The 
expansion of the core results in further hydration of the core and complete 
CaDPA release [66].  Upon completing stage II, spores have lost most of their 
resistances and are no longer considered dormant.  Then, in what has been 
described as ‘ripening,’ the germinated spore prepares for the outgrowth of a 
vegetative cell [148]. 
C. difficile spore germination is stimulated by a combination of cholic  acid 
derivatives and glycine [85, 88] and inhibited by chenodeoxycholic acid 
derivatives [85, 95, 96, 98, 137].   While many of the ultrastructural features of 
the spore are conserved between B. subtilis and C. difficile, there are many 
differences [131, 149].  Significantly, C. difficile does not encode the classical 
ger-type germinant receptor [150].  Also, C. difficile encodes a single SCLE, 
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SleC [150, 151].  C. difficile SleC is synthesized in the mother cell during spore 
formation as a preproprotein and sleC is required for colony formation by C. 
difficile spores [151, 152].  The pre-sequence is cleaved off, presumambly 
during transport across the spore outer membrane.  The proprotein remains 
inactive in the dormant spore until it is cleaved by a germination-specific 
protease, CspB [99].  In C. difficile, cspB is encoded as a fusion to cspA [99, 
150].  Upon translation of the cspBA mRNA, CspBA undergoes interdomain 
cleavage to generate both CspB and CspA proteins [99].  A third protein, CspC, 
is encoded downstream of cspBA [99, 150].  In C. perfringens, all three Csp 
proteins have predicted catalytic activity (all three possess intact catalytic triads) 
[82, 83].  In C. difficile, only CspB is predicted to have catalytic activity because 
the residues important for catalysis are mutated in cspA and cspC [98, 99, 150].  
Recently, we identified C. difficile CspC as the bile acid germinant receptor [98].  
Certain SNPs in C. difficile cspC can abrogate spore germination while other 
SNPs alter germinant specificity [98].  We proposed a model where CspC 
activates CspB proteolytic activity and CspB cleaves pro-SleC to an active form.  
Activated SleC then begins to degrade the C. difficile spore cortex [98].  
Because the C. difficile germinant receptor complex (CspA, CspB, CspC and 
SleC) is likely located in or near the spore cortex, while the B. subtilis germinant 
receptor complex is located in the spore’s inner membrane, we hypothesized 
that there may be fundamental differences between the mechanisms of 
germinant receptor-mediated C. difficile spore germination and B. subtilis spore 
germination. 
Here we investigated how C. difficile spores germinate with respect to the 
proposed stages of germination, as described for B. subtilis.  In contrast to what 
is observed for B. subtilis spore germination [and C. perfringens [81]], we found 
that cortex hydrolysis preceded DPA release during C. difficile spore 
germination.  Significantly, mutations in either the C. difficile bile acid germinant 
receptor, CspC, or the cortex hydrolase, SleC, prevented both cortex hydrolysis 
and DPA release by germinating C. difficile spores. These results suggest that 
DPA release during C. difficile spore germination may be entirely dependent on 
core swelling or changes to cortex peptidoglycan and that the hypothesized 
glycine germinant receptor is likely not located in the spore inner membrane. 
Materials and methods 
Bacteria and strains 
Wild-type C. difficile UK1 [96, 98, 153] and C. difficile M68 [113, 135, 
153], C. difficile JSC10 (cspC::ermB) [98] and C. difficile CAA5 (sleC::ermB) 
were routinely grown in an anaerobic atmosphere (10% H2, 5% CO2, 85% N2) 
at 37°C in Brain Heart Infusion agar supplemented with 5 g / L yeast extract and 
0.1% L-cysteine (BHIS).  B. subtilis PS533 and B. subtilis FB113 (cwlJ::tet 
sleB::spc) [154] were a generous gift from Dr. Peter Setlow and were routinely 
grown on DSM medium. E. coli DH5α was grown on LB medium. 
Chloramphenicol (20 µg / ml), thiamphenicol (10 µg / ml), lincomycin (10 µg / 
43 
ml), kanamycin (50 µg / ml for C. difficile, 20 µg / ml for E. coli, 7 µg / ml for B. 
subtilis), spectinomycin (100 µg / ml) or tetracycline (5 µg / ml for C. difficile, 20 µ
g / ml for B. subtilis) were added where indicated. 
Molecular biology 
To generate the TargeTron insertion into C. difficile UK1 sleC we took 
advantage of a previously described primer set [151]. The intron re-targeting 
fragment was generated using primers: sleC (128a) IBS 
(AAAAAAGCTTATAATTATCCTTACATTACTTCTTAGTGCGCCCAGATAGGGT 
G), sleC (128a) EBS1d 
(CAGATTGTACAAATGTGGTGATAACAGATAAGTCTTCTTAGGTAACTTACCT 
TTCTTTGT), sleC (128a) EBS2 
(TGAACGCAAGTTTCTAATTTCGGTTTAATGTCGATAGAGGAAAGTGTCT) 
and EBS universal (CGAAATTAGAAACTTGCGTTCAGTAAAC) using SOE-PCR 
as describe in the TargeTron manual (Sigma-Aldrich, St. Louis, MO).  The 350 
bp fragment was cloned into pCR2.1-TOPO (Life Technologies, Carlsbad, CA) to 
yield pCA2 and the sequence of the insert verified.  The 350 bp fragment was 
subcloned into the HindIII / BsrGI sites of the pJS107 TargeTron shuttle vector 
[153] to yield pJS113.  The pJS113 plasmid was introduced into B. subtilis Bs49 
using standard techniques.  B. subtilis Bs49 pJS113 was introduced into C. 
difficile UK1 via conjugal transfer, as described previously 
[98]. Tetracycline-sensitive, thiamphenicol-resistant (Tn916 transposon-negative, 
plasmid-positive) strains were identified.  These isolates were then 
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spread on BHIS medium supplemented with lincomycin to select for the 
TargeTron insertion into sleC.  Lincomycin-resistant colonies were screened by 
PCR for the presence of the TargeTron insertion into sleC, as described 
previously [151].  Isolates with the insertion were frozen down as C. difficile 
CAA5 and have the expected phenotype of a sleC mutant  (inability of spores to 
form colonies on BHIS agar supplemented with taurocholic acid) [151]. 
C. difficile CAA5 was complemented by expressing sleC in trans from the
pJS116 shuttle vector (a pMTL84151 derivative) [98, 155].  The C. difficile UK1 
sleC gene and promoter region were amplified using primers 5’sleC_Gibson 
(TACGAATTCGAGCTCGGTACCCGGGGATCCGATTATTTTCCTTTCAAAATT 
TTTGATTTATTTATGATTTATATC) and 3’sleC_Gibson 
(AGTGCCAAGCTTGCATGTCTGCAGGCCTCGAGTTAAATTAAAGGATTTAAA 
GAAGCTATTCTAGTTGTAG) and Phusion DNA polymerase (New England 
Biolabs, Beverly MA).  The resulting fragment was introduced into pJS116 
between the BamHI & XhoI restrictions sites using Gibson Assembly [156].  The 
resulting plasmid, pMF02, was introduced into C. difficile CAA5 as described 
above. 
Spore formation 
C. difficile spores were generated as described previously [96, 98, 134,
153].  B. subtilis vegetative cells were spread on DSM agar medium for spore 
production [157]. After 2 days, growth was harvested by scraping the plates and 
suspending in water. This suspension (containing vegetative cells, cell debris 
and spores) was then heated to 75°C for one hour to melt any agar that was 
scraped with spores. The suspension was centrifuged for 10 minutes at room 
temperature and 3,000 x g. The supernatant was removed and the pellet was 
resuspended in 10 mL of sterile water. To purify the spores from the vegetative 
cells and cell debris, the resuspended samples were layered on a gradient of 10 
mL 20% HistoDenz (w / v), 10 mL 50% HistoDenz (w / v), and centrifuged for 1 
hour at 4°C and 18,900 x g. The supernatant was then removed and the spore 
pellet was resuspended in 1 mL water. The purified spores were then washed 5 
times in water by centrifuging for 1 minute at room temperature and 14,000 x g.  
Monitoring the initiation of spore germination 
B. subtilis spores and C. difficile spores were heat activated for 30 
minutes at 80°C and 65°C, respectively, and then placed on ice.  The initiation of 
spore germination was monitored aerobically at 600 nm (the initiation of C. 
difficile spore germination is unaffected by the presence of oxygen).  To initiate 
B. subtilis spore germination, purified spores were suspended in 10 mM Tris, pH 
8.4 and 100 mM L-valine.  C. difficile spore germination was initiated by 
suspending spores in 10 mM Tris, pH 7.5, 150 mM NaCl, 100 mM glycine and 
10 mM taurocholic acid. 
Spores were heat shocked at either 80°C for B. subtilis or 65°C for C. 
difficile for 30 minutes. 5 uL of spores were diluted into 995 uL of buffer with or 
without germinant, mixed and the change in optical density at 600 nm was 
measured. 
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Monitoring CaDPA release 
CaDPA release was monitored in real time using terbium fluorescence 
[158]. An opaque, 96-well plate was prepared with the 125 µL of the 
germination solutions (see above) supplemented with 800 µM TbCl3. Heat-
activated spores were then sedimented for 1 minute at 14,000 x g and 
resuspended in an equal volume of water to remove any CaDPA that may have 
released due to autogerminating spores. A 5 μL sample of a 60 OD600 spore 
suspension was added to each well and CaDPA release monitored using a 
Molecular Devices Spectramax M3 fluorescence plate reader  (Molecular 
Devices, Sunnydale, CA) (excitation: 270 nm, emission: 545 nm, cutoff: 420 nm 
– appropriate wavelengths for the DPA-Tb3+ complex).  For experiments 
involving mutations in the germination pathway (i.e., B. subtilis cwlJ/sleB or C. 
difficile cspC or C. difficile sleC), the amount of CaDPA released was compared 
to that of the WT strain.  
Assaying cortex fragment release by germinating spores 
Cortex fragments were detected using an assay based on the presence 
of reducing sugars in the germination medium, as described previously [159, 
160].  Briefly, B. subtilis spores or C. difficile spores were heat activated, as 
described above, and stored on ice until use.  An 11 ml germination solution 
(see above) was prepared. Before beginning the assay, a 1.0 mL sample was 
drawn to serve as a blank for cortex fragment detection and a separate 100 μL 
sample was taken as a blank for measuring DPA release. A target spore density 
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of OD600 ≈ 3.0 yielded the best results for detecting cortex fragments. A zero 
time point sample was taken immediately after the addition of spores and 
centrifuged for 1 minute at 14000 x g. 1.0 mL of this sample was transferred to a 
fresh tube for cortex fragment analysis (see below) and 100 μL was taken to 
monitor the amount of CaDPA released. This procedure was repeated at 
selected time points until the experiment was completed. After all time points 
were collected, samples were frozen at -80°C and lyophilized.  
Lyophilized samples were resuspended in 120 μL of 3N HCl 
supplemented with 1% phenol and 0.5% β-mercaptaethanol and then 
transferred to 2 mL screw-cap tubes. Samples were then placed in a 95°C 
recirculating water bath for 4 hours. After incubation, the samples were placed 
on ice until cool and neutralized with 120 μL of 3M NaOH. To those samples, 80 
L of a saturated sodium bicarbonate solution and 80 L of a 5% acetic 
anhydride solution were added and the samples were mixed. Samples were 
incubated at room temperature for 10 minutes then transferred back to the 95°C 
water bath for 3 minutes. Samples were removed from the water bath, cooled on 
ice, 400 μL of 6.54% K2B4O7*4H2O was added to each tube and then mixed. 
The resulting solution was then heated for 7 minutes in the 95°C water bath and 
then placed on ice for 5 minutes during which the color reagent was made. This 
color reagent was made by dissolving 0.320 g p-dimethylaminobenzaldehyde in 
1.9 mL glacial acetic acid. After the p-dimethylaminobenzaldehyde was 
completely dissolved, 100uL of 10N HCl was added, the solution was mixed and 
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then 5 mL of glacial acetic acid was added. 10 0 μL of each cooled cortex 
sample was transferred to a new 1.5 mL microcentrifuge tube and 70 0 μL of the 
color solution was added. Samples were incubated in a 37°C water bath for 20 
minutes. Following incubation, 20 0 μL of each sample was transferred to a clear 
96-well plate and quantified at 585 nm using a Molecular Devices Spectramax 
M3 fluorescence plate reader (Molecular Devices, Sunnydale, CA).  As a 
positive control for reducing sugar detection, in each experiment a standard 
curve was generated using 0, 12.5, 25, 50, 100, 250, 500 and 5000 nmol N-
acetylglucosamine.  For experiments involving mutations in the germination 
pathway (i.e., B. subtilis cwlJ/sleB or C. difficile cspC or C. difficile sleC), the 
amount of cortex released was compared to that of the WT strain.  
Statistical analysis 
Data points represent the mean from three independent experiments and 
error bars represent the standard deviation from the mean.  Statistical analysis 
between time points, where indicated, was performed using a two-tailed 
Student’s T-test. 
Results 
Comparing the initiation of C. difficile and B. subtilis spore germination 
B. subtilis spore germination can be triggered via several pathways (e.g.,
nutrient-mediated activation of the ger-type germinant receptors or direct 
activation of cortex hydrolysis by CaDPA).   To begin to understand the events 
that occur during C. difficile spore germination, we compared C. difficile spore 
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germination to that of B. subtilis spore germination via activation of their 
respective germinant receptors. During spore germination, spores transition from 
a phase-bright state (dormant) to a phase-dark state (loss of dormancy).  This 
transition can be monitored spectrophotometrically by measuring the optical 
density at 600 nm of pure spore suspensions incubated under different 
conditions.  When spores respond to germinant, they release their large depot of 
CaDPA from the core.  This action results in a large and rapid decrease in the 
OD600 of the spore suspension [161].  C. difficile UK1 spores were suspended in 
buffer supplemented with either taurocholic acid and glycine or taurocholic acid 
alone and germination was monitored at 600 nm.  As described previously, 
spores rapidly germinated upon exposure to both taurocholic acid and glycine 
but not when exposed to taurocholic acid alone (Figure 8A, data not shown) [85].  
While the use of absorbance to monitor germination is convenient, it is not a 
quantitative measure of CaDPA release and can include cortex hydrolysis at 
later time points [161].  Thus, to provide a quantitative measure of DPA release, 
we monitored CaDPA release in real-time using an assay based on terbium 
fluorescence [158, 162].  C. difficile spores released CaDPA in the presence of 
taurocholic acid and glycine but not in response to taurocholic acid alone (Figure 
8A, data not shown) and completed DPA release in approximately 30 minutes 
(no further increase in DPA occurred after 30 minutes).  
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Figure 8. Comparison of the initiation of C. difficile and B. subtilis spore 
germination.  
(A) Purified C. difficile UK1 spores were suspended in buffer supplemented with 
taurocholic acid and glycine. Germination was monitored by plotting the ratio of 
the OD600 at a given time to the OD600 at time zero (●) and DPA release from 
germinating C. difficile spores was monitored using Tb3+ fluorescence and 
normalized to the maximum amount of DPA released in the indicated time frame 
(■). (B) Purified B. subtilis PS533 spores were suspended in buffer 
supplemented with l-valine and germination was monitored as described above. 
The data from the OD600 in panels A and B were converted to the percent 
change so that the curves could be directly compared. The converted OD600 
data were plotted with the DPA release data in panels C and D, respectively. 
The data represent the averages from three independent experiments, and error 
bars represent the standard deviations. 
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To compare C. difficile spore germination to that of B. subtilis, we 
incubated purified B. subtilis spores in buffer supplemented with L-valine.  As 
described previously, the absorbance of the spore suspension decreased when 
incubated in the presence of L-valine and not in the absence of L-valine (Figure 
8B, data not shown) [163]. Similarly, Tb3+ fluorescence increased when B. 
subtilis spores were suspended in buffered L-valine (indicating CaDPA release) 
but not in buffer alone (Figure 8B, data not shown). 
 So that we could directly compare the absorbance assay to the terbium 
fluorescence assay, we plotted the percent change from the absorbance assay 
and the percent maximum Tb3+ fluorescence on the same graph.  When 
analyzed in this manner, changes in the absorbance of germinating C. difficile 
spores occurred much earlier than changes observed in Tb3+ fluorescence 
(CaDPA release) (Figure 8C).   During B. subtilis spore germination, the CaDPA 
release curve closely followed that of the absorbance curve, confirming a 
previous study which demonstrated that much of the absorbance change is due 
to the released CaDPA. (Figure 8D) [161].  Because CaDPA release is one of 
the first measurable events during germinant receptor-activation of B. subtilis 
spore germination, these results suggest that there may be events occurring 
during C. difficile spore germination before CaDPA is released.  
 
 
CaDPA release precedes cortex hydrolysis release during B. subtilis spore 
germination 
When CaDPA is released from the spore core, it transits through the 
spore cortex and activates the spore cortex hydrolase, CwlJ.  CwlJ activity (and 
SleB activity) leads to the release of cortex fragments into the surrounding 
germination medium.  B. subtilis spores suspended in germination buffer 
supplemented with L-valine released most of their CaDPA within 2.5 hours 
(Figure 9A). Spores suspended in buffer alone did not release CaDPA (data not 
shown).  When we monitored for the presence of cortex fragments (as measured 
by the abundance of reducing sugars in the germination solution), we observed 
that these cortex fragments appeared after CaDPA is released (Figure 9A) and 
their presence was dependent on L-valine (data not shown).  These results 
confirm the previous observations that CaDPA release precedes cortex 
hydrolysis in B. subtilis and, importantly, that we can detect cortex fragments 
during spore germination [161]. 
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Figure 9. Comparing the release of cortex fragments and CaDPA from 
germinating B. subtilis and C. difficile spores.  
(A) Purified B. subtilis PS533 spores were suspended in buffer with l-valine. (B) 
Purified C. difficile UK1 spores were suspended in buffer with taurocholic acid 
and glycine. At the indicated time points, a sample was taken, and the amounts 
of cortex fragments (○) and CaDPA (■) in the germination solutions were 
determined. The data represent the averages from three independent 
experiments, and error bars represent the standard deviations. *, P < 0.04.
Cortex hydrolysis precedes CaDPA release during C. difficile spore germination 
Based on our observations that the optical density of germinating C. 
difficile spores decreased before the appearance of CaDPA in solution (Figure 
8C) and that the newly identified bile acid germinant receptor is likely cortex-
localized [98], we hypothesized that cortex hydrolysis may precede CaDPA 
release during C. difficile spore germination.  C. difficile UK1 spores were 
suspended in germination buffer supplemented with taurocholic acid only or both 
taurocholic acid and glycine and assayed for the presence of both cortex 
fragments and DPA in the germination solution.  Interestingly, we detected 
cortex fragment release from the germinating spores within 2 minutes of 
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germination (the earliest time point we can measure).  At this time point, CaDPA 
is either not released or below the limit of detection (Figure 9B).  At four minutes, 
the rate of cortex fragment release increased. During this time CaDPA begins to 
be released and followed closely the curve for the cortex fragments, which 
remained steady until 8 minutes after the initiation of germination (Figure 9B).  At 
8 minutes, there was a statistically significant difference between the cortex 
fragment curve and the CaDPA curve (p-val < 0.04).  Taken together, these 
results suggest that C. difficile spore cortex hydrolysis precedes CaDPA release 
during germination. 
To control for the observed differences in cortex hydrolysis and CaDPA 
release, we analyzed cortex hydrolysis in B. subtilis FB113, a strain with 
engineered mutations in both cortex hydrolases (sleB/cwlJ).  When B. subtilis 
FB113 spores were suspended in buffer supplemented with L-valine, spores 
released CaDPA (Figure 10A). However, inactivating both sleB and cwlJ cortex 
hydrolases resulted in the inability of these B. subtilis spores to hydrolyze cortex 
in response to L-valine (Figure 10A).     
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Figure 10. Genetic analysis of cortex hydrolysis and CaDPA release from 
germinating B. subtilis and C. difficile spores.  
(A) Purified B. subtilis FB113 (cwlJ::tet sleB::spc) spores were suspended in
buffer supplemented with l-valine. (B and C) C. difficile JSC10 (cspC::ermB)
spores (B) and C. difficile CAA5 (sleC::ermB) spores (C) were suspended in
buffer supplemented with taurocholic acid and glycine. At the indicated time
points, a sample was taken, and the amounts of cortex fragments (○) and
CaDPA (■) in the germination solution were determined. The data represent the
averages from three independent experiments, and error bars represent the
standard deviations.
Conversely, when C. difficile cspC spores are suspended in buffer 
supplemented with taurocholic acid and glycine, neither cortex fragments nor 
CaDPA are released  (Figure 10B); CaDPA release was restored by expressing 
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cspBAC in trans [98].  Further, inactivating the lone C. difficile SCLE, sleC, also 
prevented cortex hydrolysis and CaDPA release (Figure 10C); germination (both 
by OD600 and CaDPA release) was restored by expressing in trans a copy of C. 
difficile sleC (Figure 11).  Because C. difficile cspC still expresses the SleC 
cortex hydrolase, but CaDPA and cortex fragments are not released, these 
results suggest that cortex hydrolysis and CaDPA release during C. difficile 
spore germination are coupled. 
Figure 11. Complementing the C. difficile sleC mutation in trans. 
Analyzing spore germination in another C. difficile strain 
It was previously reported that there may be heterogeneity among C. 
difficile isolates in terms of their germination responses [164, 165].  Therefore, 
we analyzed how cortex hydrolysis and CaDPA release occurs in another C. 
difficile ribotype.  As described above for C. difficile UK1, when C. difficile M68 
spores are suspended in buffer containing taurocholic acid and glycine [but not 
taurocholic acid only (data not shown)], cortex fragments appeared in the 
germination solution before CaDPA is detected (Figure 12).  During C. difficile 
M68 spore germination, at the earliest time point of 2 minutes, there was a 
difference between cortex fragments and CaDPA (p-val < 0.001) (Figure 12).   
These results support the idea that cortex hydrolysis preceding CaDPA release 
is a general phenomenon during C. difficile spore germination and not specific to 
one isolate. Our results clearly show that the initiation of germinant receptor-
mediated C. difficile spore germination occurs through a novel pathway. 
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Figure 12. Cortex hydrolysis precedes CaDPA release during C. difficile M68 
spore germination.  
Purified C. difficile M68 spores were suspended in buffer with taurocholic acid 
and glycine. At the indicated time points, a sample was taken, and the amounts 
of cortex fragments (○) and CaDPA (■) in the germination solution were 
determined. The data represent the averages from three independent 
experiments, and error bars represent the standard deviations. *, P < 0.001. 
Discussion 
Germination by C. difficile spores seems to occur differently than for other 
spore-forming bacteria.  Upon sequencing and analysis of the C. difficile 
genome, it was apparent that C. difficile did not encode orthologues of the ger-
type germinant receptors found in other spore-forming bacteria. This suggested 
that C. difficile spores may germinate in response to unique germinants or use 
novel mechanisms to initiate spore germination or both [150].   
It has been known for approximately 30 years that certain bile acids stimulate C. 
difficile spore germination {Wilson, 1982 #24;[166]. Though much work has 
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focused on the signals that can stimulate or inhibit C. difficile spore germination, 
the proteins that responded to these signals had remained elusive.  In a genetic 
screen to select for C. difficile mutants whose spores do not respond to 
taurocholic acid as a germinant, we identified the CspC as the bile acid 
germinant receptor [98].  Due to the differences between the predicted locations 
of the C. difficile germinant receptor complex (CspC, CspB and SleC) and the 
locations of the B. subtilis spore germinants receptors (GerAA-AB-AC) we 
hypothesized that C. difficile spore germination may occur differently than that 
observed in the model organism. 
 Here we observe that C. difficile spore germination is not initiated in the 
same manner as observed for B. subtilis.  We find that cortex hydrolysis 
precedes CaDPA release during germination by C. difficile spores and that this 
seems to be a general phenomenon among C. difficile isolates; the C. difficile 
M68 strain, a different ribotype, also released cortex fragments before CaDPA.  
Unlike what is observed for B. subtilis spore germination, we could not 
genetically separate cortex hydrolysis from CaDPA release by inactivating either 
the bile acid germinant receptor or the SCLE.  Both C. difficile cspC and C. 
difficile sleC are required to hydrolyze cortex and without cortex hydrolysis the 
release of CaDPA from the core in is not observed (Figure 10B and Figure 10C, 
respectively).   
Interestingly, C. perfringens encodes orthologues of both the classical 
ger-type germinant receptor, the Csp proteases and SleC.  However, C. 
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perfringens does not germinate in response to bile acids [78, 167].  Though 
there seems to be conservation in the Csp proteases, C. perfringens CspA, 
CspB and CspC are catalytically active proteases which could activate SleC to 
stimulate cortex hydrolysis [82, 83, 159].  Mutations in C. perfringens sleC result 
in strains that still release CaDPA but do not hydrolyze cortex [81].  Thus, our 
observation that cortex hydrolysis precedes CaDPA release during C. difficile 
spore germination is not a general phenomenon among all Clostridia.  But, 
rather, that this may be a novel mechanism for stimulating germination in spore-
forming bacteria that do not encode the classical ger-type germinant receptor. 
If mutations in the bile acid germinant receptor prevent both cortex 
hydrolysis and CaDPA release from the core, how is CaDPA release mediated 
during C. difficile spore germination?  In our working model (Figure 13), 
taurocholic acid interacts with CspC which transmits the bile acid signal to CspB.  
Activated CspB, in turn, cleaves proSleC to an active hydrolase which begins to 
hydrolyze cortex, releasing cortex fragments into the surrounding milieu.  Cortex 
hydrolysis allows the germ cell wall to expand and, with it, the inner spore 
membrane.  In our model, either an unidentified protein responds to the cell wall 
expansion and triggers CaDPA release, or the expansion of the inner spore 
membrane alone triggers CaDPA release.  This would suggest a 
mechanosensitive channel is responsible for release CaDPA during C. difficile 
spore germination.  C. difficile encodes orthologues of several mechanosensitive 
proteins (e.g. mscL and mcsS) and most of these are likely to be involved in 
maintaining osmotic homeostasis during vegetative growth and probably have 
no role in spore germination [150, 168-170].   
Figure 13. Models for spore germination. 
(A) During the initiation of B. subtilis spore germination, l-alanine (or l-valine) 
interacts with the GerA germinant receptor complex (location 1). The SpoVA 
channel (which includes the SpoVAD DPA-binding protein) is then activated
(location 2), and it releases CaDPA from the spore core (3). Released CaDPA 
activates the CwlJ cortex hydrolase (location 4) triggering cortex hydrolysis. (B) 
The initiation of C. difficile spore germination is triggered when the bile acid 
germinant receptor, CspC, interacts with taurocholic acid (location 1). Activated 
CspC then activates the germination-specific protease, CspB (2), which 
processes pro-SleC to an active form (location 3), and cortex hydrolysis begins 
(location 4). Then, due to either core swelling (location 5a) or through the action 
of an unknown protein (location 5b), SpoVAC releases CaDPA (location 6).
In B. subtilis, germination is triggered through the interaction of 
germinants with the germinant receptors imbedded in the inner spore membrane 
(Figure 13).  The interaction of these germinants with their cognate receptors 
triggers CaDPA release, likely through the SpoVA channel (Figure 13) [72].  
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Then, as described above, CaDPA activates cortex hydrolysis (Figure 13).  The 
B. subtilis SpoVA complex is composed of 7 different proteins: SpoVAA, 
SpoVAB, SpoVAC, SpoVAD, SpoVAEa, SpoVAEb and SpoVAF.  Most of these 
proteins are important for both CaDPA import into the developing spore during 
sporulation and CaDPA release during germination [e.g. SpoVAD binds DPA 
[54]].  C. difficile does not encode orthologues of many of these proteins.  
However, C. difficile does encode spoVAC, spoVAD and spoVAE.  Recently, 
Velásquez and colleagues reported a function for SpoVAC [53].  In their 
manuscript, the authors determined that SpoVAC is a mechanosensitive channel 
[53].  How this protein functions during B. subtilis spore germination is unclear.  
For C. difficile spore germination, we propose that SpoVAC responds to the 
change in osmolarity that occurs upon cortex hydrolysis and then either, itself, 
provides a channel for CaDPA release or is part of a larger channel which is 
mechanically gated. 
While the C. difficile bile acid germinant receptor is known, with what 
glycine interacts is not. We speculated that the unidentified glycine germinant 
receptor may be localized to the inner membrane of the spore core thus 
providing a similar function as the B. subtilis germinant receptors [98].  However, 
because a mutation in the bile acid germinant receptor prevented both cortex 
hydrolysis and CaDPA release, we propose that the hypothesized glycine 
receptor to be either: i) part of the known C. difficile germinant receptor complex 
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(CspB, CspA, CspC and SleC) or ii) located in the inner spore membrane but 
whose activity is dependent on CspC activity. 
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CHAPTER IV 
DIPICOLINIC ACID RELEASE BY GERMINATING CLOSTRIDIUM DIFFICILE 
SPORES OCCURS THROUGH A MECHANOSENSING MECHANISM* 
In Chapter IV, we build upon our findings in Chapter III and analyze the 
mechanism of DPA release during C. difficile germination. Prior studies in B. 
subtilis had demonstrated that SpoVAC was a mechanosensing protein and 
essential for DPA packaging and release. Because C. difficile encodes a 
spoVAC orthologue, we hypothesized that DPA release could occur in response 
to the changes in osmolarity that are a result of the degradation of the spore 
cortex layer. To test this hypothesis, we germinated spores under high solute 
conditions and analyzed these effects on the release of DPA and cortex 
fragments during C. difficile spore germination.   
Introduction 
Clostridium difficile is a Gram-positive, spore forming, strict anaerobe that 
most-commonly infects immunocompromised or antibiotic treated hosts. Most 
antibiotics have broad spectrum activity which disrupts the normal microbiota 
that provides colonization resistance to C. difficile infection [171]. This disruption 
enables C. difficile to colonize and cause disease [124]. In a host, C. difficile 
secretes two toxins (TcdA and TcdB) that damage the colonic epithelium and 
* Reprinted with permission from “Dipicolinic acid release by germinating Clostridium difficile
spores occurs through a mechanosensing mechanism” Francis, MB. and Sorg, JA. mSphere.
2016 Dec 14;1(6). pii: e00306-16.
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elicit the primary symptoms of disease [172]. Though disease is caused by 
vegetative cells, it is the spore form that is responsible for transitioning the 
aerobic environment between hosts [60].  
Spores are metabolically dormant forms of bacteria that are resistant to 
many harsh conditions (e.g., heat, desiccation and antibiotics) [97, 101]. The 
spore structure is conserved across most spore-forming, Gram-positive bacteria 
and is important for maintaining the spore’s resistance properties. Contained 
within the spore core is the genomic DNA bound by small acid soluble proteins 
(SASPs) and a large quantity of Ca-dipicolinic acid (DPA) [66, 169]. The SASPs 
protect the DNA from UV damage and DPA packaging helps protect the core 
from heat by excluding water [20, 48, 173]. Surrounding the core is an inner 
spore membrane, where many of the Ger-type germinant receptors found in 
Bacilli, and most clostridia, are located [97]. Surrounding the inner membrane is 
a thin layer of germ cell wall peptidoglycan and a thick layer of specialized cortex 
peptidoglycan. In cortex peptidoglycan, many of the N-acetylmuramic acid 
residues have been converted to muramic-δ-lactam residues and are the targets 
for cortex degrading enzymes [66]. An outer membrane surrounds the cortex 
and functions as a scaffold with which to build the coat layer. In some spore-
forming bacteria, including C. difficile, an additional exosporium layer surrounds 
the spore coat [97].  
Spores remain metabolically dormant until specific signals, germinants, 
are detected by receptors (germinant receptors) in the spore. Germinant 
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recognition by germinant receptors leads to the irreversible initiation of the 
germination process. In B. subtilis, a model organism for studying sporulation 
and germination, the L-alanine germinant is recognized at the inner spore 
membrane by the GerA germinant receptor (which is composed of the GerAA-
AB-AC proteins) while L-asparagine, D-glucose, D-fructose, and K+  ions (AGFK) 
are recognized by GerB and GerK (which  are composed of GerBA-BB-BC and 
GerKA-KB-KC, respectively) [66]. The activation of these germinant receptors 
triggers the release of cations and DPA from the core. The mechanism of DPA 
release is unclear, however the proteins encoded by the spoVA operon 
(SpoVAA-AB-AC-AD-AEa-AEb-AF) play a role [53-55, 72, 174, 175]. In B. 
subtilis, the release of DPA activates the spore cortex lytic enzyme (SCLE), 
CwlJ, and the actions of CwlJ and SleB lead to cortex degradation [66]. This 
mechanism of spore germination is similar across most spore-forming bacteria 
studied to date. 
C. difficile spore germination is triggered by a combination of certain bile 
acids and amino acids [85, 95, 96, 101, 130]. In contrast to the mechanisms of 
germination observed in Bacilli and most Clostridia, C. difficile does not encode 
the Ger-type germinant receptors [150]. Instead, C. difficile uses the 
germination-specific, pseudoprotease, CspC, as the bile acid germinant receptor 
[98].  In Clostridium perfringens, CspA, CspB and CspC are active proteases 
with the potential to cleave the SCLE, pro-SleC, to its active form [81-83, 101, 
176-178]. Interestingly, C. difficile CspA and CspC are pseudoproteases, their 
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catalytic triads are not complete. Due to the apparent lack of catalytic activity, we 
proposed a working model where activated CspC signals CspB to cleave pro-
SleC to an active form. SleC activation initiates cortex degradation. Recently, 
another protein, GerS, was identified to play an important role during C. difficile 
spore germination [100]. Spores lacking GerS fail to degrade cortex but still 
process SleC into its active form [100]. In contrast to the mechanisms of 
germination observed in B. subtilis, during C. difficile spore germination the DPA 
contained within the core is released after cortex degradation begins [179]. 
Whereas B. subtilis releases DPA through a pore presumably formed by the 
proteins encoded by the spoVA operon, C. difficile does not encode the entire 
operon [150, 180]. Instead, C. difficile encodes three homologues: spoVAC, 
spoVAD and spoVAE [180]. In B. subtilis, the spoVA proteins are required for 
the completion of sporulation, likely due to defects in DPA packaging [52]; 
SpoVAD is thought to act as a DPA binding protein [54], helping to package 
DPA in the core during spore formation. Moreover, a recent study identified a 
mobile genetic element that encodes spoVAC, spoVAD and spoVAE and the 
resulting overexpression of these proteins lead to accumulation of up to 50% 
more DPA in the spores and an increased heat resistance [173]. 
B. subtilis SpoVAC was shown to have mechanosensing properties [53]. 
If SpoVAC functions as a mechanosensing protein in C. difficile, it could respond 
to the changes in osmolarity observed at the inner spore membrane due to the 
removal of constraints placed upon the dormant, dehydrated core by the cortex 
layer. Cortex degradation may allow pores to open in response to the lower 
osmotic pressure of the environment, relative to the DPA rich core. We 
hypothesized that a spore germinating in an environment with an osmolyte 
concentration equal to or higher than that of the core would affect DPA release. 
Here, we investigated the role high osmolyte concentrations have on cortex 
degradation and DPA release during C. difficile spore germination. We find that 
high osmolyte concentrations can block DPA release from the core while 
permitting cortex degradation. Our data suggest that DPA release during 
germination by C. difficile spores is due to changes in osmolarity that occur 
during cortex degradation. 
Materials and methods 
Bacteria and strains 
Wild-type C. difficile R20291 and C. difficile M68, were routinely grown 
at 37°C in an anaerobic atmosphere (10% H2, 5% CO2, 85% N2) on brain heart 
infusion agar supplemented with 5 g / L yeast extract and 0.1% L-cysteine 
(BHIS). E. coli DH5α, E. coli HB101 pRK24 and B. subtilis BS49 were grown on 
Luria-Bertani (LB) medium supplemented with antibiotics as needed. 
Chloramphenicol (20 μg / ml), thiamphenicol (10 μg/ml), kanamycin (50 μg / 
ml for C. difficile, 20 μg / ml for E. coli), or tetracycline (5 μg / ml for C. difficile 
and 20 μg / ml for B. subtilis) were added where indicated.  
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Molecular biology 
Using the codA-dependent allelic exchange strategy [181], we engineered 
a deletion of spoVAC in C. difficile R20291. To do so, we inserted the Tn916 
oriT inserted into pMTL-SC7215, using primers pMTL_SC_7215_tn916_L 
(ctagagtcgacgtcacgcgtccatggagatctcgagtaacatcttctatttttcccaaatccttac) and 
pMTL_SC_7215_tn916_R 
(ggccagtgccaagcttgcatgtctgcaggcctcgagctaaagggaatgtagataaattattaggtaatctgc), 
to make pMF12, as described previously [98]. C. difficile R20291 DNA was used 
as a template to amplify 1kb upstream and downstream of the spoVAC deletion 
using primers spoVAC_ndeI_L 
(agctatgaccgcggccgctgtatccatatgagttcaaaatggagatgaagaggcaaaaga) 
spoVAC_LHF_Rev_II 
(ctaaaacatcttaaaaatataataaataatgtctacatattttttataatttttatcca) spoVAC_xhoI_L 
(atggataaaaattataaaaaatatgtagacattatttattatatttttaagatgttttagatgat) 
spoVAC_xhoI_R 
(tgccaagcttgcatgtctgcaggcctcgaggttctttaaggttaaacatctctataccac). The resulting 1 
kb fragments were stitched together using SOE PCR and subcloned into pMF12 
digested with NdeI / XhoI, yielding pMF11.  The pMF11 plasmid was introduced 
into B. subtilis BS49 using standard techniques. Subsequently, the pMF11 
plasmid was introduced into C. difficile R20291 via conjugal transfer from B. 
subtilis BS49 pMF11, as described previously [98]. Tetracycline-sensitive, 
thiamphenicol-resistant (transposon-negative, plasmid-positive) strains were 
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identified. These isolates were then spread on BHIS supplemented with 
kanamycin and thiamphenicol to enrich for and identify faster growing single-
crossover integrant clones. The larger colonies were then selected and plated on 
CDMM supplemented with 50 μg / ml 5-fluorocytosine (FC). The colonies formed 
after 48 hours were tested for thiamphenicol sensitivity by culturing and by PCR 
with primers 5’catP3 (atggtatttgaaaaaattgataaaaatag) and 3’ catP2 
(ttaactatttatcaattcctgcaattcg) to confirm loss of the plasmid. To confirm the 
deletion in spoVAC, the colonies were screened by PCR amplification of the 
spoVAC surrounding region using spoVAC_ndeI_L and spoVAC_xhoI_R. In 
order to generate the spoVAC-complementing plasmid, C. difficile spoVAC was 
amplified using Phusion polymerase with the 5’spoVAC_Gibson 
(catgattacgaattcgagctcggtacccggggatcctaatacttatgatatgtagaataacaaaatataataaat 
atattact) and 3’spoVAC_Gibson 
(ccagtgccaagcttgcatgtctgcaggcctcgagatctagtggtggtggtggtggtgtagagtatttgctatctgtt 
gaatcgtat) oligonucleotides. The resulting fragment was cloned by Gibson 
Assembly [156] between the BamHI and XhoI restriction sites of the B. subtilis – 
C. difficile shuttle vector, pJS116, to generate pMF15. The nucleotide sequences 
were confirmed before use. 
Spore formation 
C. difficile strains were plated on reduced BHIS plates and allowed to
grow for 4 days, as described previously [85, 96, 179]. On day 4, growth was 
harvested from two plates by scraping the plates with a disposable inoculating 
loop and suspended into 1.5 mL microcentrifuge tubes containing 1 mL sterile 
water. Tubes were stored at 4 °C overnight. The next day, the contents of each 
tube were resuspended through pipetting and immediately centrifuged for 1 
minute at 14,000 x g. The supernatant was removed and the pellet was 
resuspended in water and centrifuged for 1 minute at 14,000 x g and was 
repeated for a total of 5 times. After resuspending the pellet again in 1 mL of 
water, the contents of 2 tubes (2 mL total suspension) were carefully layered 
over 8 mL of 60% sucrose (w / v). This was centrifuged for 20 minutes at 4,000 x 
g. Subsequently, the supernatant was removed and the remaining pellet was 
suspended in 1 mL of sterile water. As above, spores were washed 5 times in 
sterile water. After the final wash, the supernatant was removed and the purified 
spore preparations were combined in 1 mL of sterile water. After purification, the 
resulting spore suspension was phase bright and >99.9% of vegetative cells 
removed. 
Monitoring the initiation of spore germination 
The initiation of spore germination was monitored aerobically at 600 nm 
(the initiation of C. difficile spore germination is unaffected by the presence of 
oxygen). C. difficile spore germination was initiated by suspending spores in 50 
mM HEPES (pH 7.5), 100 mM NaCl, 100 mM glycine, 10 mM taurocholate and 
19% or 38% w / v of sucrose or trehalose or sorbitol.  Prior to germination, 
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spores were heat shocked for 30 min at 65 °C and then placed on ice. Then, 5 
μl of spores was diluted into 995 μl of germination buffer (above), mixed, and the 
change in optical density at 600 nm (OD600) was measured over time.  
Monitoring DPA release 
DPA release was monitored in real-time using terbium fluorescence, as 
described previously [101, 179]. Briefly, an opaque, 96-well plate was prepared 
with the 125 μl of the germination solutions (see above) supplemented with 800 
μM TbCl3. A 5-μl sample of a spore suspension (OD600 of 60) was added to 
each well, and the DPA release was monitored using a Molecular Devices 
Spectramax M3 fluorescence plate reader (Molecular Devices, Sunnyvale, CA) 
[excitation, 270 nm; emission, 545 nm; cutoff, 420 nm (appropriate wavelengths 
for the DPA-Tb3+ complex)].  
Protein extraction and Western blotting 
Spores were allowed to germinate in germination buffer (above).  
NuPAGE soluble proteins (e.g. SleC) were extracted from 2 × 109 / ml purified 
spores, as described previously [101]. Proteins were separated by SDS-PAGE 
and then transferred for 1.5 hours at 0.75 Amp to an Immobilon-P PVDF 0.45 
µm membrane (Millipore). Subsequently, the membrane was blocked for 1 hour 
at room temperature in Tris-buffered saline (TBS) supplemented with 1% (vol / 
vol) Tween*20 (TBST) and 5% dried, skimmed milk. The membrane was then 
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incubated at room temperature for 1 hour with rabbit anti-SleC antisera. After 
incubation with the primary antibody, membranes were washed thrice in TBST 
for 20 minutes each. The membranes were then labeled with goat anti-rabbit IgG 
(Life Technologies) for 1 hour at room temperature. The membranes were again 
washed as described above and then exposed to CN/DAB in peroxide substrate 
buffer. To stop reaction, membranes were rinsed with water and photographed 
under white light. 
Assaying cortex fragment release by germinating spores 
Cortex fragments were detected according to the method previously 
reported [179, 182]. Briefly, C. difficile spores were heat activated, as described 
above, and stored on ice until use. A pre-inoculation 1.0-ml sample was drawn 
to serve as a blank for cortex fragment detection and a separate 100-μl sample 
was taken as a blank for measuring DPA release. A target spore density (OD600) 
of ∼3.0 yielded the best results for detecting cortex fragments except for MBF02 
spores which required a spore density of ~3.5. A 1.1 mL zero time point sample 
was taken immediately after the addition of spores to the germination buffer and 
centrifuged for 1 min at 14,000 × g. Then, 1.0 ml of this sample was transferred 
to a fresh tube for cortex fragment analysis, and 100 μl was taken to monitor the 
amount of DPA released. This procedure was repeated at selected time points 
until the experiment was completed. After all time point samples were collected, 
the samples were frozen at −80°C and lyophilized.  
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Lyophilized samples were then analyzed for cortex fragments as 
previously described [182]. 
Statistical analysis 
Data points represent the mean from three independent experiments and 
error bars represent the standard error from the mean. Statistical analysis 
between time points, where indicated, was performed using a two-tailed 
Student’s t test.  
Results 
Measuring DPA content of SpoVAC deficient spores 
In a previous study, we determined that cortex degradation precedes 
DPA release and hypothesized that SpoVAC may trigger the SpoVA channel to 
release DPA in a mechanosensing fashion [179]. Recently, a mutation in 
spoVAC was shown to affect packaging and release of DPA from the C. difficile 
spore [180]. Using the CodA-based allelic exchange system [181], we created a 
mutant strain in which the spoVAC sequence was truncated where only the first 
30 base pairs and last 30 base pairs of spoVAC were present. Spores were 
prepared from wild-type C. difficile R20291, C. difficile MBF02 (ΔspoVAC) and 
C. difficile MBF02 pMB15 (pspoVAC).  The DPA content of these spores was 
measured by boiling the spores, a condition that artificially releases the stored 
DPA [98]. Similar to the results of a recent study [180], spores derived from the 
spoVAC mutant strain contained approximately 1% of the DPA content that is 
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found in the wild-type strain (Figure 14) and this could be complemented by 
expressing spoVAC in trans. These results confirm the prior observations that 
spoVAC is important for packaging DPA during spore formation [180]. 
Figure 14. SpoVAC is important for DPA packaging. 
Equal amounts of spores derived from C. difficile strains R20291 (WT), MBF02 
(ΔspoVAC) and MBF02 pMF15 (pspoVAC) were boiled for 15 minutes and the 
amount of DPA was quantified using Tb3+ fluorescence.  The data represent the 
average from three independent experiments and the error bars represent the 
standard deviation from the mean.  All values are reported as a percent of C. 
difficile R20291 release. * = P < 0.001; ** = P < 0.05 
High sorbitol concentrations delay the onset of C. difficile spore germination 
To test the effects of osmolytes on C. difficile spore germination, we 
measured the change in OD600 nm of spores suspended in either buffer 
supplemented with TA and glycine or buffer supplemented with TA, glycine and 
osmolyte (either sorbitol, trehalose or sucrose).  The OD germination assay is a 
simple method for observing how germination proceeds on the whole (the 
change from a phase bright spore to a phase dark spore) but does not give 
detailed information about individual steps (e.g., DPA release or cortex 
degradation). When C. difficile R20291 spores were suspended in buffer 
supplemented with both TA and glycine, a rapid decrease in the OD600 of the 
suspension was observed.  However, when C. difficile R20291 spores were 
suspended in buffer supplemented with TA, glycine and increasing amounts of 
sorbitol (0%, 19% and 38%), the wild-type spores demonstrated a significant 
delay in the drop in OD600 (Figure 15A), suggesting that the increasing osmolyte 
concentration blocked or slowed C. difficile spore germination. 
To understand if the above observations were due to sorbitol alone or if 
other osmolytes could substitute for sorbitol, we measure germination in either 
trehalose (Figure 15B) or sucrose (Figure 15C).  As observed for germination in 
the presence of sorbitol, C. difficile spores germinating in the presence of 19% 
trehalose or sucrose lead to a small delay in germination.  However, C. difficile 
spore germination was significantly delayed in the presence of 38% trehalose or 
sucrose (Figure 15B and Figure 15C, respectively).  The results suggest that C. 
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difficile spore germination can be delayed under increased osmolyte 
concentrations. 
Figure 15. Osmolytes delay germination by C. difficile spores. 
C. difficile R20291 spores were germinated in buffer supplemented with 
taurocholate and glycine in the absence of sorbitol (•) or in buffer supplemented 
with 19% () or 38% () osmolyte. (A) sorbitol; (B) trehalose; (C) sucrose. For 
clarity, every 5th data point is plotted and the data represent the averages from 
three independent experiments. Error bars represent the standard deviations 
from the mean. * = P <0.01; $ = P <0.05
Osmolytes block DPA release during C. difficile spore germination 
To understand if the osmolyte-mediated delay in germination by C. 
difficile spores was specific to the OD assay or if we would observe similar 
observations for DPA release, we monitored DPA release by germinating spores 
in the presence of TbCl3 [159, 183]. During germination, the released DPA 
complexes with Tb3+ resulting in fluorescence of the lanthanide metal.  Thus, 
DPA release by germinating spores is measured in real time by monitoring DPA-
dependent Tb3+ fluorescence. C. difficile R20291 spores were added to buffer 
supplemented with TA and glycine alone or TA, glycine and sorbitol and DPA 
release was monitored as a readout for germination (Figure 16A). In the 
absence of sorbitol, spores rapidly release their stored DPA and an increase in 
Tb3+ fluorescence is observed (Figure 16A). Interestingly, spores delayed the 
release of DPA in the presence of sorbitol.  We found that 38% sorbitol lead to a 
delay of ~8 minutes over the course of the experiment (Figure 16A). To 
understand if DPA release could be blocked / delayed by other osmolytes, 
spores were germinated as above but sorbitol was substituted with trehalose 
(Figure 16B) or sucrose (Figure 16C).  Both trehalose and sucrose delayed DPA 
release by germinating C. difficile spores.  
79 
80 
Figure 16. Osmolytes delay DPA release by C. difficile spores. 
C. difficile R20291 spores were suspended  in buffer containing terbium chloride 
and glycine alone (•), supplemented with taurocholate () or supplemented with 
taurocholate and  38% (Δ) osmolyte. (A) sorbitol; (B) trehalose; (C) sucrose. For 
clarity, every 5th data point is plotted and the data represent the averages from 
three independent experiments. Error bars represent the standard deviations 
from the mean. * = P ≤ 0.01. Statistical significance between TA + glycine 
conditions and 38% sorbitol conditions was only tested at the 20 and 60 minutes 
time points.
Prior reports have suggested that there is heterogeneity between different 
C. difficile strains in terms of their response to germinants [101, 164, 165].
Though the rates and efficiencies with which C. difficile spores germinate in 
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response to bile acids are reported, the mechanisms underlying the response to 
germinants are likely conserved among strains [101, 179, 184]. To ensure that 
our observations that high osmolyte concentrations delay the release of DPA 
from germinating C. difficile spores are not due to a strain-specific phenotype, 
we determined if the C. difficile M68 strain would yield similar results.  DPA 
release by C. difficile M68, ribotype 017, spores was delayed by increased 
sorbitol or trehalose or sucrose concentrations (Figure 17).  These results 
suggest that the effects of high osmolyte concentrations on C. difficile spore 
germination are not strain specific and that high osmolyte concentrations delay 
the release of DPA from the core of germinating C. difficile spores. 
 
Figure 17. Osmolytes delay DPA release by C. difficile M68 spores. 
C. difficile M68 spores were suspended in buffer containing terbium chloride and 
glycine alone (●), supplemented with taurocholate (▲) or supplemented with 
taurocholate and  38% (Δ) osmolyte. (A) sorbitol; (B) trehalose; (C) sucrose. For 
clarity, every 5th data point is plotted and the data represent the averages from 
three independent experiments. Error bars represent the standard deviations 
from the mean.
Pro-SleC is cleaved to an active form in high osmolyte concentrations 
The delay in OD change and in DPA release could be the result of the 
high osmolyte concentration retarding the rate at which germinants (TA and 
glycine) interacted with the germinant receptors. To test if the germinants were 
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still activating germination in the presence of osmolyte, we tested if the SCLE, 
pro-SleC, was cleaved to its active form (SleC activation is necessary for cortex 
degradation). C. difficile spores were suspended in buffer with glycine only, as a 
negative control, or in buffer supplemented with TA and glycine with or without 
38% osmolyte. Samples were taken at the indicated times and processed for 
immunoblotting. In the absence of TA, spores do not activate pro-SleC (Figure 
18). However, spores rapidly cleave pro-SleC to its active form in response to 
TA and glycine. Significantly, the presence of osmolyte had no effect on the 
timing of SleC activation (Figure 18).  
Figure 18. High osmolyte concentrations do not affect SleC activation. 
Cleavage of pro-SleC (*) to SleC (**) was assayed in buffer supplemented with 
glycine or buffer glycine and taurocholate with or without 38% osmolyte at 5, 10 
and 30 minutes. 
Detecting cortex degradation in the presence of osmolytes 
If SleC is activated in the presence of osmolyte, the appearance of cortex 
fragments in the germinant solution should be readily detected. To detect these 
fragments, we made use of a colorimetric assay that we, and others, have used 
to quantify the presence of reducing sugars [81, 178, 179, 182]. This assay 
detects the presence N-acetylglucosamine (NAG) and N-acetylmuramic acid 
(NAM) residues (reducing sugars) released during the degradation of cortex 
peptidoglycan [182]. Purified spores were germinated in the presence of TA and 
glycine and were sampled every 2 minutes for the presence of both cortex 
fragments and DPA (Figure 19). The results for C. difficile R20291 spores were 
similar to those previously reported for C. difficile strain UK1, where cortex 
degradation and DPA release seemingly occur simultaneously (Figure 19A) for a 
wild-type strain [using mutant strains, we previously observed that cortex 
degradation precedes DPA release [179]]. When we tested cortex degradation 
and DPA release in buffer supplemented with 38% sorbitol with TA and glycine 
(sorbitol was the only osmolyte tested in this assay because it is the only 
compound tested that does not generate a reducing end), the release of cortex 
fragments occurs in a similar manner as in the absence of sorbitol while DPA 
release is delayed and only begins to be observed after 8 minutes (Figure 19B).  
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Figure 19. High osmolyte concentrations delay DPA release but not cortex 
degradation.  
Purified C. difficile R20291 spores (A and B), C. difficile MBF02 (ΔspoVAC) 
spores (C and D) or C. difficile MBF02 pMF15 (pspoVAC) spores (E and F) 
suspended in buffer supplemented with taurocholate and glycine and no sorbitol 
(A, C and E) or the same buffer supplemented with 38% sorbitol (B, D and F). At 
the indicated time points, samples were taken for the amount of (•) cortex 
fragments and (○) DPA. Values for all graphs are normalized to average, 
maximum, amount of cortex or DPA released by each strain in the absence of 
sorbitol. The data represent the averages from three independent experiments 
and error bars represent the standard deviation from the mean. 
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When germinated in TA with glycine, C. difficile MBF02 (ΔspoVAC) 
spores released cortex fragments similarly to the wild-type strain (Figure 19C).  
DPA release by this strain also occurs, however the total amount of DPA in the 
MBF02 strain is only 1% of that found in the R20291 strain (Figure 14).  When 
the spoVAC-mutant spores were germinated in the presence of 38% sorbitol, 
the release of what little amount of DPA is present is delayed to the very end of 
the time period, while cortex degradation remains largely unaffected (Figure 
19D). These observations could be complemented by expressing spoVAC in 
trans from a plasmid (Figure 19E and Figure 19F). 
Altering osmolyte concentration affects DPA release during germination 
If DPA release is dependent on both cortex degradation and on a 
mechanosensing mechanism, changing the osmolyte concentration during 
germination should result in a marked change in the rate of DPA release. To test 
the effects of an osmotic downshift on DPA release by germinating spores, 
spores were allowed to germinate for 5 minutes in one volume of 38% sorbitol-
containing germination buffer (containing TA and glycine). Then, either two 
volumes of germination buffer with sorbitol (leading to no change in osmotic 
conditions) or two volumes of the germination buffer without sorbitol (leading to 
an osmotic downshift) were then added to the well. Germination was then 
monitored under these new conditions.  In samples that had sorbitol-containing 
germination buffer added, DPA release was delayed, as expected – the osmotic 
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strength of the solution did not change (Figure 20).  However, diluting the 
osmolyte to 12.7% (a three-fold dilution) resulted in a rapid release of DPA from 
the core (Figure 20). As controls, samples where the spores were germinated in 
germination buffer alone or germination buffer supplemented with 38% sorbitol 
for the duration of the experiment were included.   As expected, in the control 
samples, DPA was released in the no-sorbitol-containing germination buffer 
while the sorbitol-containing germination buffer blocked DPA release (Figure 
20).   These results suggest that DPA release during germination by C. difficile 
spores occurs through a mechanosensing mechanism that is dependent on 
degradation of the spore cortex layer.  
 
 
 
 
Figure 20. Altering osmotic conditions during germination influences DPA 
release.  
Purified C. difficile R20291 spores were suspended in buffer supplemented with 
taurocholate and glycine alone () or the presence of with 38% sorbitol (♦) and 
allowed to germinate for 10 minutes. In a separate experiment, spores were 
germinated for 5 minutes in buffer supplemented with taurocholate and glycine 
alone (Δ) or with 38% sorbitol (○).  These samples then were diluted with 2 
volumes of buffer supplemented with taurocholate and glycine alone. Finally, a 
separate set of spores were germinated for 5 minutes in buffer supplemented 
with taurocholate, glycine and 38% sorbitol (•) and then 2 volumes of 38% 
sorbitol-containing germination buffer were added and germination continued for 
another 5 minutes.  
Discussion 
The release of DPA from the core of a spore is a crucial step during spore 
germination. However, the mechanisms of DPA release by germinating spores 
are poorly understood. Here, we have reaffirmed that SpoVAC plays a critical 
role in DPA import into the core during spore formation (Figure 14) [180]. 
Unfortunately, our current understanding of the mechanism of DPA release and 
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SpoVAC activity prevents the separation of DPA packaging during C. difficile 
spore formation and DPA release during germination. Thus, to begin to 
understand the mechanisms of DPA release by germinating C. difficile spores, 
we raised the concentration of osmolytes in the germination solution. The 
increase in osmolyte concentration led to a marked delay in DPA release but not 
a delay in the activation of SleC, a key step in germination (Figure 16 and Figure 
18). By using an assay that detects the presence of reducing sugars (i.e., cortex 
fragments) [182], we were able to compare when the cortex was degraded 
relative to DPA release in conditions where the osmotic strength of the medium 
was increased. Under these conditions, DPA release is delayed, though cortex 
degradation is unaffected (Figure 19). Because cortex degradation precedes 
DPA release during C. difficile spore germination, these results suggest that 
cortex degradation relieves the constraints put in place by the cortex on the core 
leading to the mechanosensing protein, SpoVAC, permitting DPA release. 
spoVAC is conserved across most endospore-forming organisms and the 
proteins encoded by the spoVA operon play important roles during spore-
formation and germination [52, 173, 180, 185]. In B. subtilis, formation of a 
dormant, heat-resistant spore is dependent on 5 of the proteins encoded in the 
spoVA operon: spoVAA, -AB, -AC, -AD, and –AEb . SpoVAF and SpoVAEa 
localize to the inner membrane of the spore and have minor roles during spore 
germination [55]. Defects in these proteins reduce germinant-dependent 
germination but do not affect non-nutrient-mediated spore germination (e.g., 
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exogenous DPA) [55]. In B. subtilis, the release of DPA from the core triggers 
degradation of the spore cortex [66]. For DPA to be released from the spore 
core, a signal first must be transmitted from the germinant receptors to the 
SpoVA protein. SpoVAF and SpoVAEa may play accessory roles during 
germination to efficiently receive and transmit the germination signal from the 
GerA or GerB/GerK to the SpoVA complex and permit DPA release.  
Importantly, C. difficile does not encode ger-type germinant receptors nor does 
C. difficile encode spoVAF but it does encode spoVAE and spoVAD homologs 
[150]. The roles of SpoVAE and SpoVAD during C. difficile spore germination 
are unknown.  However, based on work in B. subtilis, it is likely that SpoVAD is 
essential for DPA packaging during sporulation [54]. 
Of the spoVA encoded proteins, SpoVAC is nearly universally conserved 
among spore formers [185].  Though the number of proteins encoded by the 
spoVA operon varies between organisms, nearly all encode spoVAC.  However, 
there are a few exceptions.  In the Clostridiales, Bryantella formatexigens only 
encodes spoVAA and spoVAB and Carboxydibrachium pacificum does not 
encode any apparent spoVA homologs [185].  Because of the nearly-universal 
conservation of spoVAC among spore-formers, this suggests that 
mechanosensing plays an important role during spore germination.  
Mechanosensing during spore germination was previously studied during 
germination by B. subtilis spores [168-170].  The authors found that B. subtilis 
ΔmscL ΔmscS germinated similarly to a wild type strain in response to L-alanine 
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and dodecylamine [170].  Thus, the proteins required for osmotic stability during 
growth play little to no role during germination by B. subtilis spores.  However, 
the mechanosensing SpoVAC protein plays an important role during spore 
formation and germination [52, 180]. 
The data supporting SpoVAC as a mechanosensing protein is based, 
partly, on the ability of recombinantly expressed SpoVAC-myc-6His to protect E. 
coli from an osmotic downshift [53].  The authors found that SpoVAC-myc-6His 
protected E. coli to a similar extent as MscL, a well-studied mechanosensing 
membrane protein [186, 187].  The authors further characterized the protein 
using conductance studies and found that, when recombinantly expressed in E. 
coli and embedded in lipid vesicles, SpoVAC has a pore size of 4.6 Å [53].  This 
pore size should be large enough to accommodate DPA (a planar molecule with 
dimensions of 5.2 Å in length x 3.5 Å in width) but the authors mention that the 
vesicles may not recapitulate the lipid content or the hydration state of the inner 
spore membrane and this could affect gating of the protein [53].  Prior work has 
suggested that inner spore membrane to be in a gel-like state (or in a state that 
prevents mobility of protein within the membrane) [188]. An interesting 
hypothesis is that upon the initiation of cortex degradation, local changes at the 
inner membrane are observed which triggers SpoVAC-mediated DPA release 
from the core.  Subsequently, the change in hydration state of the inner spore 
membrane at the site of DPA release results in the signal propagating to the 
surrounding SpoVAC proteins.  The prediction of such a system would be that 
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high osmolyte concentrations could only block DPA release for so long before a 
few SpoVAC proteins become activated, randomly.  This then would trigger the 
rest of the SpoVAC proteins to open and allow DPA to escape the core.  In 
support of this hypothesis, we find that sorbitol or trehalose or sucrose do not 
permanently block the release of DPA from germinating spores (Figure 16 and 
Figure 17).  These osmolytes only delay the release of DPA from the 
germinating spore. For sorbitol-containing germination buffer, the rate with which 
DPA is released after the initial delay is similar to the rate in the absence of 
sorbitol (Figure 16A).  This would suggest that the SpoVAC channel activity is 
not affected by sorbitol, or water activity, in our assays. In this experiment, 
sucrose functioned better than trehalose and trehalose functioned better than 
sorbitol but DPA release still occurs and the rate of DPA release begins to 
increase at later time points. Importantly, though, what little DPA is present in 
the C. difficile ΔspoVAC strain is still released during spore germination [(Figure 
19C), though the value is presented as 100% release, the data are normalized 
between +/- sorbitol conditions and not between strains.  The ΔspoVAC mutant 
has a low amount of DPA (Figure 14) [180]].  This might suggest that another 
protein could function in an accessory role to permit DPA release in response to 
the change in osmolarity at the inner spore membrane upon cortex degradation 
or that the membranes leak DPA in the absence of SpoVAC. 
Understanding the process of germination and how DPA release is 
triggered is likely more straightforward in C. difficile than in other spore-forming 
 93 
 
organisms.  Because only spoVAC, spoVAD and spoVAE are encoded in C. 
difficile, the mechanism of DPA release likely does not involve the interaction with 
other factors (e.g., germinant receptors).  In C. difficile, the bile acid germinant 
receptor, CspC, likely transmits the bile acid signal to CspB which then cleaves 
pro-SleC to an active, cortex-degrading, form [98, 99, 189]. Activated SleC then 
begins degrading cortex allowing expansion and SpoVAC-mediated DPA release, 
core hydration and subsequent outgrowth of a vegetative cell.  The absence of 
germinant receptor in the inner spore membrane simplifies the mechanism of DPA 
release but may result in less specificity and a tendency for increased amount of 
spontaneous DPA release.  Interestingly, Clostridium perfringens encodes a 
spoVA system similar to that of C. difficile and also encodes functional germinant 
receptors [79, 101, 167, 185]. How DPA release is signaled in this organism is 
unknown but its understanding would be of important value for understanding how 
the SpoVAD, SpoVAC and SpoVAE interact in such a system. 
 
 
 
 
 
 
CHAPTER V 
SUMMARY OF FUTURE DIRECTIONS OF C. DIFFICILE GERMINATION 
RESEARCH 
Introduction 
With the advent of improved genetic tools, C. difficile research has begun 
to target specific genes for clean deletions. Previously, the limited genetic 
toolbox only allowed for the disruption of individual genes based on the ability to 
insert antibiotic resistance genes, e.g. the TargeTron system.  This system has 
many limitations, including potential polar effects and off-target insertion events. 
Recently, allelic exchange techniques have been developed, allowing for the 
clean deletion of target genes, as with spoVAC in Chapter IV. Currently, 
CRISPR techniques are being developed in our lab that will allow improved gene 
deletions.  
With these improved tools, the future direction of this research is to first 
determine the role that spoVAD and spoVAE play in spore formation, DPA 
packaging, germination and DPA release. SpoVAD, based upon research in B. 
subtilis, is expected to play a role in packaging of the DPA during spore 
formation. Removal of spoVAD is expected to result in spores with less DPA. 
The role SpoVAE plays is less clear. It could be associated with pore opening, 
i.e. the observed result (based on DPA release) of all SpoVAC pores appearing 
to open collectively. Alternatively, SpoVAE could be associated with allowing of 
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SpoVAC, functioning in a manner similar to the hypothesized role SpoVAEa and 
SpoVAF that affects the rate of DPA release in B. subtilis.  
When compared with the functions of the B. subtilis spoVA operon, the 
role of the smaller spoVACDE of C. difficile may not be the same. An interesting 
experiment will be replacing the entire spoVA operon in B. subtilis with the C. 
difficile spoVACDE. This could result in a B. subtilis spore that would still 
package DPA but release of DPA would be affected. Presumably, the C. difficile 
SpoVAC would be incapable of interacting with the Ger proteins. Germination of 
these spores would then only occur when CwlJ is activated by exogenous DPA. 
In this pathway, CwlJ would degrade the cortex, allowing the core of the B. 
subtilis spore to swell and then the C. difficile SpoVAC-related pore would open, 
allowing DPA release. The purpose of these experiments would be to see if C. 
difficile-like germination could be reconstituted in B. subtilis.  
In tandem with understanding the process of DPA packaging and release, 
research will also focus on the transition in the spore occurring as the core 
rehydrates and the spore becomes a vegetative cell. During this stage, termed 
ripening, metabolic functions begin to resume within the spore. This is an 
important stage, as the spore has lost its resistance properties but has not fully 
resumed the ability to mount a proper stress response. It is at this point, when 
the DPA is released and the core rehydrates, translation of stored RNA is 
believed to initiate. Understanding these initial products could be important for 
targeting infections at this vulnerable stage.  
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Another area of on-going research related to this dissertation is the role of 
amino acids in C. difficile germination. How the amino acids interact with the 
germination complex is currently unknown. It is unclear if the amino acid co-
germinant interacts directly at CspC with TA or if it is interacting at another 
location within the germination complex. It may act to assist in the release of 
members of the germination complex (CspC, CspB, SleC) from GerS or from 
each other, i.e. releasing active SleC from CspBC. Earlier attempts using the 
similar mutagenesis method that isolated CspC as the bile acid germinant 
receptor failed to successfully isolate the amino acid germinant receptor. 
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